<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">73360</article-id><article-id pub-id-type="doi">10.7554/eLife.73360</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>TIGAR deficiency enhances skeletal muscle thermogenesis by increasing neuromuscular junction cholinergic signaling</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-251151"><name><surname>Tang</surname><given-names>Yan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1377-422X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-253451"><name><surname>Zong</surname><given-names>Haihong</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-253452"><name><surname>Kwon</surname><given-names>Hyokjoon</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-253453"><name><surname>Qiu</surname><given-names>Yunping</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-253454"><name><surname>Pessin</surname><given-names>Jacob B</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-253455"><name><surname>Wu</surname><given-names>Licheng</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-253456"><name><surname>Buddo</surname><given-names>Katherine A</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-253457"><name><surname>Boykov</surname><given-names>Ilya</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-208483"><name><surname>Schmidt</surname><given-names>Cameron A</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-253458"><name><surname>Lin</surname><given-names>Chien-Te</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-132009"><name><surname>Neufer</surname><given-names>P Darrell</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-253459"><name><surname>Schwartz</surname><given-names>Gary J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-253460"><name><surname>Kurland</surname><given-names>Irwin J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-5968"><name><surname>Pessin</surname><given-names>Jeffrey E</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2041-2726</contrib-id><email>jeffrey.pessin@einsteinmed.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05cf8a891</institution-id><institution>Departments of Medicine, Albert Einstein College of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Bronx</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01vx35703</institution-id><institution>East Carolina Diabetes and Obesity Institute and the Department of Physiology, Brody School of Medicine East Carolina University</institution></institution-wrap><addr-line><named-content content-type="city">Greenville</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05cf8a891</institution-id><institution>Departments of Neuroscience, Albert Einstein College of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Bronx</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05cf8a891</institution-id><institution>The Fleischer Institute of Diabetes and Metabolism, Albert Einstein College of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Bronx</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05cf8a891</institution-id><institution>Departments of Molecular Pharmacology, Albert Einstein College of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Bronx</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Elmquist</surname><given-names>Joel K</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00t9vx427</institution-id><institution>University of Texas Southwestern Medical Center</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Wong</surname><given-names>Ma-Li</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/040kfrw16</institution-id><institution>State University of New York Upstate Medical University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>07</day><month>03</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e73360</elocation-id><history><date date-type="received" iso-8601-date="2021-08-25"><day>25</day><month>08</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-03-02"><day>02</day><month>03</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2021-09-30"><day>30</day><month>09</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.09.28.462124"/></event></pub-history><permissions><copyright-statement>© 2022, Tang et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Tang et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-73360-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-73360-figures-v2.pdf"/><abstract><p>Cholinergic and sympathetic counter-regulatory networks control numerous physiological functions, including learning/memory/cognition, stress responsiveness, blood pressure, heart rate, and energy balance. As neurons primarily utilize glucose as their primary metabolic energy source, we generated mice with increased glycolysis in cholinergic neurons by specific deletion of the fructose-2,6-phosphatase protein TIGAR. Steady-state and stable isotope flux analyses demonstrated increased rates of glycolysis, acetyl-CoA production, acetylcholine levels, and density of neuromuscular synaptic junction clusters with enhanced acetylcholine release. The increase in cholinergic signaling reduced blood pressure and heart rate with a remarkable resistance to cold-induced hypothermia. These data directly demonstrate that increased cholinergic signaling through the modulation of glycolysis has several metabolic benefits particularly to increase energy expenditure and heat production upon cold exposure.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>TIGAR</kwd><kwd>cholinergic neurons</kwd><kwd>acetylcholine</kwd><kwd>neuromuscular junction</kwd><kwd>skeletal muscle thermogenesis</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>DK033823</award-id><principal-award-recipient><name><surname>Pessin</surname><given-names>Jeffrey</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>DK020541</award-id><principal-award-recipient><name><surname>Pessin</surname><given-names>Jeffrey</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution>S10 SIG Award for the Sciex 6500+QTRAP</institution></institution-wrap></funding-source><award-id>1S10OD021798</award-id><principal-award-recipient><name><surname>Kurland</surname><given-names>Irwin J</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>TIGAR deficiency in cholinergic neuron enhanced intracellular acetyl-CoA levels and pyruvate dehydrogenase flux into the TCA cycle that drives increased cholinergic tone with reduced heart rate and blood pressure and raised resistance against the paralytic curare and cold-induced hypothermia.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>TIGAR (Tp53-induced glycolysis and apoptosis regulator) was originally identified as a p53-inducible protein that functions as a fructose-2,6-bisphosphatase (F2,6P) but subsequently shown to have phosphatase activities for a variety of phosphorylated metabolic intermediates and allosteric regulators including 2,3-bisphospholgycerate (2,3BPG), 2-phosphoglycerate, phosphoglycolate, and phosphoenolpyruvate (<xref ref-type="bibr" rid="bib5">Bensaad et al., 2006</xref>; <xref ref-type="bibr" rid="bib45">Rigden, 2008</xref>; <xref ref-type="bibr" rid="bib9">Bolaños, 2014</xref>; <xref ref-type="bibr" rid="bib52">Tang et al., 2021</xref>). Due to its F2,6P dephosphorylation activity, TIGAR is generally considered a suppressor of glycolysis as F2,6P is a potent allosteric activator for 6-phosphofructo-1-kinase (PFK1), the rate-limiting step in glycolysis. However, the dephosphorylation of 2,3BPG to generate 3-phosphoglycerate would also be expected to increase glycolysis (<xref ref-type="bibr" rid="bib9">Bolaños, 2014</xref>). In addition, the role of TIGAR in regulating carbohydrate metabolism is also complicated by the presence of the related phosphofructokinase bis-phosphatase (PFKBP) family that has both F6P 2-kinase and F2,6P bisphosphatase activities (<xref ref-type="bibr" rid="bib39">Mor et al., 2011</xref>). Thus, the biological readout of TIGAR function is likely to be highly cell context dependent. In this regard, TIGAR has been reported to differentially modulate multiple different pathophysiological outcomes. For example, in the brain TIGAR expression was reported to protect against ischemic/reperfusion injury (<xref ref-type="bibr" rid="bib33">Li et al., 2021</xref>), whereas in the heart TIGAR deficiency protected myocardial infarction (<xref ref-type="bibr" rid="bib25">Hoshino et al., 2012</xref>) and in pressure-overloaded hearts (<xref ref-type="bibr" rid="bib43">Okawa et al., 2019</xref>). In cancer models, TIGAR plays a complex role in the formation and progression of different types of cancer via suppressing aerobic glycolysis and controlling reactive oxygen species (ROS) production (<xref ref-type="bibr" rid="bib52">Tang et al., 2021</xref>). Recently, it has been reported that TIGAR can both enhance the development of premalignances and suppress the metastasis of cancer invasion by the way of inhibition of ROS production (<xref ref-type="bibr" rid="bib13">Cheung et al., 2020</xref>).</p><p>As carbohydrate metabolism and glycolysis are essential normal physiological processes in all cells and tissues, we have examined the metabolic phenotype of whole-body and tissue-specific TIGAR knockout mice. Surprisingly, we have observed that TIGAR deficiency in cholinergic neurons of mice results in a marked protection against hypothermia following an acute cold challenge. At a molecular level, this results from enhanced acetylcholine levels and increased cholinergic signaling at the neuromuscular junction (NMJ) driving skeletal muscle shivering-induced thermogenesis.</p></sec><sec id="s2" sec-type="results"><title>Results</title><p>Previously we reported that the TIGAR can modulate NF-kB signaling through a direct binding interaction and inhibition of the E3 ligase activity of the linear ubiquitin-binding assembly complex, LUBAC, in cultured cells (<xref ref-type="bibr" rid="bib51">Tang et al., 2018</xref>). To examine the role of TIGAR in vivo, we initially generated whole-body <italic>Tigar</italic> knockout (TKO) mice. Surprisingly, however, during our phenotypic characterization we observed that the TKO male and female mice both display a remarkable resistance to cold induced-hypothermia. As shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>, both male (panel A) and female (panel B) control mice when shifted from room temperature to a 4°C environment display the typical 4–5°C decline in core body temperature during the 1 hr acute exposure period. In contrast, the TKO male and female mice only display less than a 1°C decline in core body temperature under identical conditions. The level of <italic>Ucp1</italic> mRNA (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>) and protein (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>) was not significantly different in interscapular brown adipose tissue (iBAT) at room temperature. <italic>Ucp1</italic> mRNA did increase approximately 1.5-fold following 1 hr cold exposure, but this was not significantly different between the control and TKO mice. Although a very small amount of <italic>Ucp1</italic> mRNA was detected in inguinal adipose tissue (iWAT) of control mice at room temperature, it was lower in the TKO mice (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>). Moreover, following 4°C exposure for 2 hr there was an increase in <italic>Ucp1</italic> mRNA indicative of beige adipocyte induction. However, the induction of <italic>Ucp1</italic> mRNA was significantly reduced in the TKO mice compared to the control mice, probably due to decreased sensitivity of cold-induced sympathetic activation (see Figure 7).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title><italic>TIGAR</italic> deficiency mice are resistant to hypothermia induced by an acute cold challenge.</title><p>(<bold>A</bold>) Male mice (wild type [WT] n = 10, whole-body <italic>Tigar</italic> knockout [TKO] n = 6) and (<bold>B</bold>) female mice (WT n = 6, TKO n = 7) core body temperatures were measured every 15 min starting at ambient laboratory temperature (0 min) and following placement at 4°C. (<bold>C</bold>) Representative TIGAR immunoblot of gastrocnemius muscle (Gastroc), epididymal white adipose tissue (EWAT), subcutaneous inguinal white adipose tissue (iWAT), and interscapular brown adipose tissue (iBAT) from the control <italic>Tigar<sup>fl/fl</sup></italic> and adipocyte-specific knockout <italic>Tigar<sup>fl/fl</sup></italic>/<italic>Adipoq<sup>Cre</sup></italic> mice. (<bold>D</bold>) <italic>Tigar<sup>fl/fl</sup></italic> and <italic>Tigar<sup>fl/</sup>fl/Adipoq<sup>Cre</sup></italic> male mice (n = 6) core body temperatures were measured every 15 min starting at ambient laboratory temperature (0 min) and following placement at 4°C. (<bold>E</bold>) Representative UCP1 and TIGAR immunoblots of brown adipose tissue from WT, TKO, <italic>Ucp1</italic> knockout (UKO), and <italic>Ucp1</italic> and <italic>Tigar</italic> double knockout (UTKO) mice from two independent genotypes each. (<bold>F</bold>) WT (n = 6), TKO (n = 6), UKO (n = 7), and UTKO (n = 8) mice core body temperatures were measured every 15 min starting at ambient laboratory temperature (0 min) and following placement at 4°C. (<bold>G</bold>) Representative TIGAR immunoblot of heart, gastrocnemius muscle (Gastroc), extensor digitorum digitorum longus (EDL), and soleus muscle from the control (<italic>Myl1<sup>Cre</sup></italic>) and skeletal muscle-specific TKO (<italic>Myl1<sup>Cre</sup>/Tigar<sup>fl/fl</sup></italic>) mice. (<bold>H</bold>) <italic>Myl1<sup>Cre</sup></italic> and <italic>Myl1<sup>Cr&gt;</sup>/Tigar<sup>fl/fl</sup></italic> male mice (n = 6) core body temperatures were measured every 15 min starting at ambient laboratory temperature (0 min) and following placement at 4°C. Statistical analyses are described in ‘Methods details,’ and the data are presented as the mean ± SD. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001, <sup>§</sup>p&lt;0.001.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Fresh gastrocnemius muscle (Gastr), epididymal adipose tissue (EWAT), inguinal white adipose tissue, and interscapular brown adipose tissue from <italic>Tigar<sup>fl/fl</sup></italic> and <italic>Tigar<sup>fl/fl&gt;</sup>/Adipoq<sup>Cre</sup></italic> mice were collected, and 30 μg of the tissue lysate were used for TIGAR (30 kDa) immunoblotting analysis as described in the ‘Immunoblotting’ section.</title><p>The raw image was used for <xref ref-type="fig" rid="fig1">Figure 1C</xref>. A detailed description of the raw images is shown in <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>.</p></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-73360-fig1-data1-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Interscapular brown adipose tissues were collected from wild type (WT), whole-body <italic>Tigar</italic> knockout (TKO), <italic>Ucp1</italic> knockout (UKO), and <italic>Ucp1</italic> and <italic>Tigar</italic> double knockout (UTKO) mice, and 30 μg of the tissue lysate were used for TIGAR (30 kDa) immunoblotting analysis as described in the ‘Immunoblotting’ section.</title><p>The raw image was used for <xref ref-type="fig" rid="fig1">Figure 1E</xref>. A detailed description of the raw images is shown in <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>.</p></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-73360-fig1-data2-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata3"><label>Figure 1—source data 3.</label><caption><title>Interscapular brown adipose tissues were collected from wild type (WT), whole-body <italic>Tigar</italic> knockout (TKO), <italic>Ucp1</italic> knockout (UKO), and <italic>Ucp1</italic> and <italic>Tigar</italic> double knockout (UTKO) mice, and 30 μg of the tissue lysate were used for UCP1 (33 kDa) immunoblotting analysis as described in the ‘Immunoblotting’ section.</title><p>The raw image was used for <xref ref-type="fig" rid="fig1">Figure 1E</xref>. A detailed description of the raw images is shown in <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>.</p></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-73360-fig1-data3-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata4"><label>Figure 1—source data 4.</label><caption><title>Interscapular brown adipose tissues were collected from wild type (WT), whole-body <italic>Tigar</italic> knockout (TKO), <italic>Ucp1</italic> knockout (UKO), and <italic>Ucp1</italic> and <italic>Tigar</italic> double knockout (UTKO) mice, and 30 μg of the tissue lysate were used for vinculin (117 kDa) immunoblotting analysis as described in the ‘Immunoblotting’ section.</title><p>The raw image was used for <xref ref-type="fig" rid="fig1">Figure 1E</xref>. A detailed description of the raw images is shown in <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>.</p></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-73360-fig1-data4-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata5"><label>Figure 1—source data 5.</label><caption><title>Fresh heart, gastrocnemius muscle (Gastr), extensor digitorum longus (EDL muscle), and soleus muscle were collected from <italic>Myl1<sup>Cre</sup></italic> and <italic>Myl1<sup>Cre</sup>/Tigar<sup>fl/fl</sup></italic> mice, and 30 μg of the tissue lysate were used for TIGAR (30 kDa) immunoblotting analysis as described in the ‘Immunoblotting’ section.</title><p>The raw image was used for <xref ref-type="fig" rid="fig1">Figure 1G</xref>. A detailed description of the raw images is shown in <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>.</p></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-73360-fig1-data5-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata6"><label>Figure 1—source data 6.</label><caption><title>Fresh heart, gastrocnemius muscle (Gastr), extensor digitorum longus (EDL muscle), and soleus muscle were collected from <italic>Myl1<sup>Cre</sup></italic> and <italic>Myl1<sup>Cre</sup>/Tigar<sup>fl/fl</sup></italic> mice, and 30 μg of the tissue lysate were used for vinculin (117 kDa) immunoblotting analysis as described in the ‘Immunoblotting’ section.</title><p>The raw image was used for <xref ref-type="fig" rid="fig1">Figure 1G</xref>. A detailed description of the raw images is shown in <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>.</p></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-73360-fig1-data6-v2.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73360-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>The whole-body <italic>Tigar</italic> knockout (TKO) protection against hypothermia is independent of UCP1 expression with no change in basal metabolic rate.</title><p>(<bold>A</bold>) Relative <italic>Ucp1</italic> mRNA levels in interscapular brown adipose tissue from wild type (WT) and TKO male (n = 6) mice maintained at ambient temperature and after 1 hr 4°C exposure. (<bold>B</bold>) Representative TIGAR, UCP1, and actin protein immunoblot of interscapular brown adipose tissue from two independent WT and TKO male mice maintained at ambient temperature or after 1 hr 4°C exposure. (<bold>C</bold>) Relative <italic>Ucp1</italic> mRNA levels in inguinal adipose tissue from the WT and TKO male mice (n = 4–10) at ambient temperature or after 2 hr 4°C exposure. Please note that the Ct values for brown adipose tissue were approximately 18, whereas the Ct values for the inguinal white adipose tissue were in the range of 33. (<bold>D</bold>) The ratio of lean mass/body weight and fat mass/body weight was determined by EchoMRI at 5 months of age for male WT and TKO mice. (<bold>E</bold>) Representative images of hematoxylin and eosin staining of soleus and extensor digitorium longus (EDL) skeletal muscle from the WT and TKO mice. (<bold>F</bold>) Quantification of daily food intake/body weight in the light and dark cycles of WT and TKO male mice. (<bold>G</bold>) Indirect calorimetry determination of spontaneous locomotor activity in the AMB + Z dimensions from the WT and TKO mice in the light and dark cycles. (<bold>H</bold>) Indirect calorimetry determination of energy expenditure in the light and dark cycles of the WT and TKO mice. Statistical analyses are described in ‘Method details’ and the data are presented as the mean ± SD. **p&lt;0.01, <italic>****</italic>p&lt;0.0001.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Interscapular brown adipose tissues were collected from both ambient temperature housed and 4°C 1 hrexposed wild type (WT) and whole-body <italic>Tigar</italic> knockout (TKO), mice and 30 μg of the tissue lysate were used for TIGAR (30 kDa) immunoblotting analysis as described in the ‘Immunoblotting section.</title><p>The raw image was used for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>. A detailed description of the raw images is shown in <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>.</p></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-73360-fig1-figsupp1-data1-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata2"><label>Figure 1—figure supplement 1—source data 2.</label><caption><title>Interscapular brown adipose tissues were collected from both ambient temperature housed and 4°C 1 hr exposed wild type (WT) and whole-body <italic>Tigar</italic> knockout (TKO) mice, and 30 μg of the tissue lysate were used for UCP1 (33 kDa) immunoblotting analysis as described in the ‘Immunoblotting’ section.</title><p>The raw image was used for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>. A detailed description of the raw images is shown in <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>.</p></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-73360-fig1-figsupp1-data2-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata3"><label>Figure 1—figure supplement 1—source data 3.</label><caption><title>Interscapular brown adipose tissues were collected from both ambient temperature housed and 4°C 1 hr exposed wild type (WT) and whole-body <italic>Tigar</italic> knockout (TKO) mice, and 30 μg of the tissue lysate were used for actin β immunoblotting analysis as described in the ‘Immunoblotting’ section.</title><p>The raw image was used for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>. A detailed description of the raw images is shown in <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>.</p></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-73360-fig1-figsupp1-data3-v2.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73360-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Changes in the expression of skeletal muscle SERCA, myoregulin, and sarcolipin do not account for the differential sensitivity to tubocurare.</title><p>Relative mRNA levels of (<bold>A</bold>) <italic>Atp2a1,</italic> (<bold>B</bold>) <italic>Atp2a2,</italic> (<bold>C</bold>) myoregulin (<italic>Mrln</italic>), and (<bold>D</bold>) sarcolipin (<italic>Sln</italic>) in the gastrocnemius muscle from male (n = 3–10) wild type (WT) and whole-body <italic>Tigar</italic> knockout (TKO) mice at ambient temperature or after 1 hr 4°C exposure. Statistical analyses are described in ‘Method details,,’ and the data are presented as the mean ± SD.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73360-fig1-figsupp2-v2.tif"/></fig></fig-group><p>Changes in tissue distribution of muscle and fat mass as well as modulation of basal energy expenditure have important roles in the control of thermogenesis. However, there was no significant difference in the relative fat mass or lean mass (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>) between the control and TKO mice. Hematoxylin and eosin (H&amp;E) staining of oxidative soleus and glycolytic extensor digitorum longus (EDL) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>) skeletal muscle also indicated the absence of any gross morphological differences between the control and TKO mice. Similarly, food intake (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>), spontaneous locomotor activity in the AMB + Z dimensions (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1G</xref>), and energy expenditure (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1H</xref>) were essentially identical.</p><p>As the TKO mice are whole-body knockouts, the temperature phenotype could result from an effect on a single or combinatorial number of cell types. We first generated <italic>Tigar<sup>fl/fl</sup></italic> mice that were crossed with <italic>Adipoq<sup>Cre</sup></italic> mice to generate adipocyte-specific TKO mice (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). These mice had the identical temperature sensitivity as the control <italic>Tigar<sup>fl/fl</sup></italic> mice both displaying an approximately 4°C decline in core body temperature following exposure to 4°C for 1 hr (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). To further rule out BAT as a contributor to the enhanced cold protection in the TKO mice, we crossed the cold-sensitive <italic>Ucp1</italic>-deficient mice (<xref ref-type="bibr" rid="bib15">Enerbäck et al., 1997</xref>) with the TKO mice (both strains with C57BL/6J background) to produce wild type (WT), TKO, UKO, and <italic>Ucp1<sup>-/-</sup>/Tigar<sup>-/-</sup></italic> double knockout (UTKO) mice (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). As expected, UKO mice were highly cold sensitive compared to their WT littermates following a 1 hr acute cold exposure (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). Interestingly, the UTKO mice displayed a strong cold resistance, which was not significantly different from the TKO littermates. These data strongly suggest that thermogenic adipose tissue is not responsible for the resistance to hypothermia in the TKO mice.</p><p>Since skeletal muscle plays a major role in heat production, we next generated skeletal muscle-specific TKO mice by crossing the <italic>Tigar<sup>fl/fl</sup></italic> mice with the skeletal muscle-specific myosin light polypeptide 1-Cre (<italic>Myl1<sup>Cre</sup></italic>) mice (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). TIGAR is highly expressed in skeletal muscle, with the highest protein levels in depots containing glycolytic fibers (white gastrocnemius and EDL) skeletal muscle. The <italic>Myl1<sup>Cre</sup></italic>-driven TIGAR deletion resulted in efficient loss of TIGAR protein in all skeletal muscles examined with no effect on the heart (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). Similar to the adipocyte-specific TKO mice, skeletal muscle <italic>Tigar</italic>-deficient mice had no significant resistance to acute cold exposure (<xref ref-type="fig" rid="fig1">Figure 1H</xref>). Moreover, we did not find any significant change in skeletal muscle mRNA expression of sarco-/endoplasmic reticulum Ca<sup>2+</sup>-ATPase (SERCA1, <italic>Atp2a1; SERCA2, Atp2a2</italic>) in control or TKO mice maintained at room temperature or shifted to 4°C for 1 hr (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A and B</xref>). Similarly, there was no change in myoregulin (<italic>Mrln</italic>) (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2C</xref>). Although there was a small apparent increase in sarcolipin (<italic>Sln</italic>) mRNA in the control WT mice shifted to 4°C, there was no statistical difference with the TKO mice (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2D</xref>). Together, these data are consistent with the absence of a cell-autonomous effect in either thermogenic adipocytes or skeletal muscle.</p><p>To unravel these unexpected findings, we next undertook a pharmacological approach to address the ability of the TKO mice to resist hypothermia. Treatment of control and TKO mice with the selective SERCA inhibitor cyclopiazonic acid (CPA) (<xref ref-type="bibr" rid="bib55">Wang et al., 2021</xref>) reduced core body temperature at room temperature (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). As expected, CPA treatment resulted in a faster rate of decline and to a lower extent when the mice were exposed to 4°C (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). However, there was no significant difference in the response to CPA between the control and TKO mice. The CPA-induced reduction in body temperature is directly correlated with observable skeletal muscle paralysis, consistent with skeletal muscle contraction activity as an important component in thermal regulation (<xref ref-type="bibr" rid="bib7">Blondin and Haman, 2018</xref>), and further indicates that SERCA functions downstream of TIGAR function.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>TIGAR knockout mice are resistant to tubocurare but not cyclopiazonic acid (CPA).</title><p>(<bold>A</bold>) Wild type (WT) and whole-body <italic>Tigar</italic> knockout (TKO) male mice (n = 6) were intraperitoneally injected with CPA (10 mg/kg body weight), and then core body temperature was measured every 15 min at room temperature. (<bold>B</bold>) WT and TKO male mice (n = 6) were intraperitoneally injected with CPA (10 mg/kg body weight) at room temperature, and then shifted to 4°C for 30 min, with core body temperature measured every 15 min. (<bold>C</bold>) WT and TKO male mice (n = 6) were intraperitoneally injected with tubocurare (0.4 mg/kg body weight), and then core body temperature was measured every 10 minutes at room temperature. (<bold>D</bold>) WT and TKO male mice (n = 6) were intraperitoneally injected with tubocurare (0.4 mg/kg body weight) at room temperature, and then 10 min later shifted to 4°C for 30 min, with core body temperature measured every 10 min. (<bold>E</bold>) WT and TKO female mice (n = 6) were intraperitoneally injected with tubocurare (0.15 mg/kg body weight), and then core body temperature was measured every 15 min at room temperature. (<bold>F</bold>) WT and TKO male mice (n = 10) were intraperitoneally injected with different tubocurare doses, and the LD<sub>50</sub> of curare was calculated using an online software LD<sub>50</sub> Calculator (AAT Bioquest, Inc, Sunnyvale, CA). (<bold>G</bold>) WT and TKO male mice (n = 10) were intraperitoneally injected with a lethal tubocurare dose (0.6 mg/kg body weight), and the number of mice undergoing complete paralysis was plotted as a function of time in seconds. (<bold>H</bold>) The time to death (absence of respiration) of the same mice was plotted as a function of time in minutes. Statistical analyses are described in ‘Method details,’ and the data are presented as the mean ± SD. *p&lt;0.05, <italic>**</italic>p&lt;0.01, <italic>***</italic>p&lt;0.001, ****p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73360-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Changes in the expression of skeletal muscle nicotinic acetylcholine receptor subunits do not account for the differential sensitivity to tubocurare.</title><p>Relative mRNA levels of the nicotinic acetylcholine receptor subunits (<bold>A</bold>) α1 (<italic>Chrna1</italic>), (<bold>B</bold>) β1 (<italic>Chrnb1</italic>), (<bold>C</bold>) γ (<italic>Chrng</italic>), (<bold>D</bold>) δ (<italic>Chrnd</italic>), and (<bold>E</bold>) ε (<italic>Chrne</italic>) in the gastrocnemius muscle from male (n = 3–10) wild type (WT) and whole-body <italic>Tigar</italic> knockout (TKO) mice at ambient temperature or after 1 hr 4°C exposure. Statistical analyses are described in ‘Method details,’ and the data are presented as the mean ± SD.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73360-fig2-figsupp1-v2.tif"/></fig><media id="fig2video1" mime-subtype="mp4" mimetype="video" xlink:href="elife-73360-fig2-video1.mp4"><label>Figure 2—video 1.</label><caption><title>Whole-body <italic>Tigar</italic> knockout (TKO) mice are resistant to the paralytic effects of tubocurare.</title><p>Representative video clip of wild type (WT) and TKO male mice behavior under ambient temperature and at 4°C following intraperitoneal (IP) injection of tubocurare (0.4 mg/kg body weight). Rectal temperature recording of WT and TKO mice with curare injection was performed on February 12, 2019. The date of birth of both WT and TKO mice was October 15, 2018. The body weights of WT and TKO were 25.3 g and 27.6 g, respectively. The volume of curare saline solution (0.1 mg/ml in saline) for IP injection was 101.2 µl for the WT mouse and 110.4 µl for the TKO mouse. The mice were IP injected with curare, then caged at ambient temperature (21–23°C) for 10 min, and subsequently transferred into a pre-chilled cage in a cold chamber at 4°C for 20 min. The mice were taken back to the cages at ambient temperature (see the sketch below). Rectal temperature was recorded at the time of curare injection and every 10 min thereafter (see the table in text). The mouse in the left cage is WT, and the mouse in the right cage is TKO.</p></caption></media></fig-group><p>Since <italic>Tigar</italic> deficiency in neither adipocytes nor skeletal muscle recapitulated the protection of acute hypothermia but that paralysis results in a rapid reduction in core body temperature, we next assessed whether the cold resistance of the TKO mice was due to shivering thermogenesis (ST). To address this, we next treated mice with the highly specific skeletal muscle nicotinic acetylcholine receptor competitive antagonist tubocurare (<xref ref-type="bibr" rid="bib10">Bowman, 2006</xref>). Control male mice treated with 0.4 mg/kg tubocurare became relatively inactive with essentially no detectable locomotor activity at room temperature 10 min post injection that lasted for another 20–30 min (see <xref ref-type="video" rid="fig2video1">Figure 2—video 1</xref>). Over this time period, there was a concomitant decline in core body temperature that began to recover as the effects of tubocurare began to wear off (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Tubocurare treatment of the TKO male mice at room temperature also displayed a similar decline and recovery of body temperature but that remained somewhat higher than the control mice (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). However, shifting the male mice to 4°C following tubocurare injection resulted in a rapid decline in body temperature such that by 30 min the control mice’s body temperature was reduced to less than 25°C (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). In contrast, the tubocurare-injected TKO male mice only display a reduction in body temperature to approximately 34°C under identical conditions. Moreover, while the tubocurare-treated control mice placed at 4°C remained completely immobile, the TKO mice display apparent normal locomotor activity (<xref ref-type="video" rid="fig2video1">Figure 2—video 1</xref>). Female mice are more sensitive to tubocurare than male mice (<xref ref-type="bibr" rid="bib36">Maurya et al., 2013</xref>). The body temperature in WT female mice kept declining in 1 hr period after a lower dose (0.15 mg/kg) tubocurare injection at ambient temperature. Nevertheless, the decline of body temperature in the TKO female mice was resistant to the effects of tubocurare (<xref ref-type="fig" rid="fig2">Figure 2E</xref>).</p><p>The tubocurare dose-response for male mice is shown in <xref ref-type="fig" rid="fig2">Figure 2F</xref>, with the control WT mice having an LD<sub>50</sub> of 0.44 mg/kg whereas the TKO mice having an LD<sub>50</sub> of 0.55 mg/kg (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). Injection of a lethal tubocurare dose (0.60 mg/kg) initially resulted in 50% if the control mice display a loss of voluntary locomotor activity by 150 s, but this required 240 s in the TKO mice (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). At 10 min, 100% of the control mice were dead, whereas it took nearly 25 min for 100% of the TKO mice to die (<xref ref-type="fig" rid="fig2">Figure 2H</xref>). The tubocurare resistance of the TKO mice was not due to the changes in expression of the nicotinic acetylcholine receptor subunits with no significant differences in the skeletal muscle expression of the α1 (<italic>Chrna1</italic>), β1 (<italic>Chrnb1</italic>), or γ (<italic>Chrng</italic>) subunits (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A–C</xref>) and with a small reduction in the d (<italic>Chrnd</italic>) and ε (<italic>Chrne</italic>) subunits (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D and E</xref>) in the TKO mice. These data suggest that the protection against hypothermia was due to cholinergic signaling to the skeletal muscle.</p><p>Consistent with increased skeletal muscle energetic demand, ATP levels were significantly decreased with an apparent increase in ADP and AMP in the TKO mice after 1 hr at 4°C (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Stable isotope metabolic flux assessment with H<sub>2</sub>O<sup>18</sup> demonstrated increased incorporation of orthophosphate into ATP, ADP, and AMP in the TKO mice at 4°C, which was not significantly different at room temperature (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Plasma creatine was also increased twofold in the TKO at 4°C (<xref ref-type="fig" rid="fig3">Figure 3C</xref>), reflecting the increased phosphocreatine turnover (CP M4 phosphate fragment <italic>m/z</italic> 83, <xref ref-type="fig" rid="fig3">Figure 3D</xref>). The appearance of creatine in the plasma is likely due, in part, to the increased rate of shivering that is known to induce skeletal muscle leakage (<xref ref-type="bibr" rid="bib3">Baird et al., 2012</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>TIGAR-deficient mice display increased ATP turnover in skeletal muscle.</title><p>(<bold>A</bold>) Wild type (WT) and whole-body <italic>Tigar</italic> knockout (TKO) male mice (n = 6) were maintained at room temperature (RT) or shifted to 4°C for 1 hr. Quadricep white skeletal muscles were isolated, and extracts assayed for ATP, ADP, and AMP levels as described in ‘Method details.’ (<bold>B</bold>) WT and TKO male mice (n = 3–4 per condition) were kept at RT or shifted to 4°C for 1 hr and then given an oral gavage of 0.3 ml pure H<sub>2</sub>O<sup>18</sup> for 10 min at 4°C and an intraperitoneal (IP) injection of 1 ml pure H<sub>2</sub>O<sup>18</sup> for another 10 min at 4°C. The quadricep muscles were freeze-clamped with liquid N<sub>2</sub> and extracts prepared for mass spectroscopic analyses. The heatmap shows the O<sup>18</sup> enrichment fraction of ATP, ADP, AMP, and creatine-phosphate. (<bold>C</bold>) WT and TKO male mice (n = 6) were maintained at RT or shifted to 4°C for 1 hr, and plasma creatine levels were determined by metabolomics analyses. (<bold>D</bold>) The CP_M4_83 data was generated from the same experimental setting as (<bold>B</bold>), indicating the increase in phosphocreatine turnover in TKO compared to that in WT at 4°C. Statistical analyses are described in ‘Method details,’ and the data are presented as the mean ± SD. *p&lt;0.05, ***p&lt;0.01.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Raw <sup>18</sup>O enrichment data of stable isotope metabolic flux assessment with H<sub>2</sub><sup>18</sup>O was collected in quadricep white muscle of both ambient temperature housed and 4°C 1 hr exposed wild type (WT) and whole-body <italic>Tigar</italic> knockout (TKO) mice, as described in ‘Method details’.</title><p>The data was used in <xref ref-type="fig" rid="fig3">Figure 3</xref>.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73360-fig3-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73360-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Skeletal muscles of whole-body <italic>Tigar</italic> knockout (TKO) mice at 4°C display increased pentose phosphate pathway, purine nucleotide cycle, and amino acid utilization pathways.</title><p>Wild type (WT) and TKO male mice (n = 6) were maintained at room temperature (RT) or shifted to 4°C for 1 hr. (<bold>A</bold>) Quadricep white skeletal muscles were isolated, and extracts were subjected to widely targeted (multiple reaction monitoring [MRM]) small metabolite profiling using an ABSciex 6500 + QTRAP with ACE PFP and Merck ZIC-pHILIC columns as described in ‘Materials and methods.’ The heatmap shows the metabolites/pathways differentially identified with the corresponding p-values. (<bold>B</bold>) Matched pathways, determined from MetaboAnalyst 5.0, which integrates enrichment analysis (metabolite over-representation more than expected by chance) and pathway impact (reflecting the centrality of the metabolite in a topological network).</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Raw metabolites data were collected in the gastrocnemius muscle of both ambient temperature housed and 4°C 1 hr exposed wild type (WT) and whole-body <italic>Tigar</italic> knockout (TKO) mice as described in ‘Method details’.</title><p>The data was used in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73360-fig3-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73360-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>TIGAR deficiency has no significant effect on intrinsic skeletal muscle mitochondrial oxidative phosphorylation activity or ATP production.</title><p>Permeabilized skeletal muscle fiber bundles were prepared from red portions of the gastrocnemius muscle from wild type (WT) and whole-body <italic>Tigar</italic> knockout (TKO) mice immediately after 1 hr cold exposure. (<bold>A</bold>) Oxygen consumption rate (<italic>J</italic>O<sub>2</sub>) as a function of ADP concentration. (<bold>B</bold>) The K<sub>m</sub> and V<sub>max</sub> for ADP-stimulatory respiratory kinetics. (<bold>C</bold>) Rates of ATP production (<italic>J</italic>ATP) and (<bold>D</bold>) oxygen consumption (<italic>J</italic>O<sub>2</sub>) measured simultaneously under clamped submaximal and maximal ADP-demand states. (<bold>E</bold>) ATP/O efficiency ratios. (<bold>F</bold>) Force-frequency of the extensor digitorum longus muscle isolated from the WT and TKO mice. (<bold>G</bold>) Peak-specific tension and time to one-half relaxation of the extensor digitorum longus muscle from the WT and TKO mice.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73360-fig3-figsupp2-v2.tif"/></fig></fig-group><p>The mechanics of energetic supply at 4°C was further examined by using a widely targeted LC/MS/MS protocol (<xref ref-type="bibr" rid="bib25">Hoshino et al., 2012</xref>). Key pathways found to be significant were pentose phosphate pathway, purine nucleotide cycle, and amino acid utilization pathways (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). The pentose phosphate pathway cycle fills the purine nucleotide cycle that acts in concert with the malate-aspartate shuttle and the TCA cycle to preserve cellular energetics (<xref ref-type="bibr" rid="bib22">Hatazawa et al., 2015</xref>). In particular, glycine/serine, histidine, and methionine metabolism also drives the input of the tricarboxylic acid cycle intermediates serving as anapleurotic inputs (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>). Together, these interactions serve to recycle AMP generated by increased skeletal muscle energy demand.</p><p>Mitochondria are a primary source of both ATP production and heat generation during muscle contraction. To determine whether mitochondrial oxidative phosphorylation (OXPHOS) efficiency and/or capacity are altered in TKO mice, permeabilized skeletal muscle fiber bundles were prepared from red portions of the gastrocnemius muscle from the control and TKO mice immediately after 1 hr cold exposure. ADP-stimulated respiratory kinetics (i.e., K<sub>m</sub> and V<sub>max</sub>) were virtually identical between WT and TKO muscle during respiration supported by carbohydrate (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A and B</xref>) and/or lipid-based substrates. Rates of ATP production (<italic>J</italic>ATP) and oxygen consumption (<italic>J</italic>O<sub>2</sub>) measured simultaneously under clamped submaximal and maximal ADP-demand states were also similar in muscle from the control and TKO mice (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2C and D</xref>), yielding similar ATP/O efficiency ratios (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2E</xref>). Finally, in vitro studies of the EDL muscle showed no differences in force-frequency, peak specific tension, or time to one-half relaxation between the control and TKO mice (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2F and G</xref>). Together, these data indicate that the skeletal muscle contraction-induced thermogenesis in TKO mice is not due to any intrinsic change in skeletal muscle mitochondrial efficiency of contractile function and therefore must result from a change in signaling that in turn drives an enhanced skeletal muscle response.</p><p>Since the TKO mice are resistant to tubocurare and the major driver of skeletal muscle contraction is cholinergic signaling, we next generated cholinergic neuron-specific <italic>Tigar</italic> knockout (chTKO) mice using the choline acetyl-CoA transferase <italic>ChAT-Cre</italic> mice (<xref ref-type="bibr" rid="bib47">Rossi et al., 2011</xref>). As the superior cervical ganglion (SCG) is composed of approximately 80% cholinergic neurons (<xref ref-type="bibr" rid="bib54">Wang et al., 1990</xref>; <xref ref-type="bibr" rid="bib40">Morales et al., 1995</xref>; <xref ref-type="bibr" rid="bib29">Juranek and Wojtkiewicz, 2015</xref>), we collected the fresh SCGs (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>) and confirmed that <italic>Chat<sup>Cre</sup></italic> resulted in the loss of <italic>Tigar</italic> in cholinergic neurons by immunofluorescence co-localization of TIGAR with the vesicular choline transporter (VChAT) (<xref ref-type="fig" rid="fig4">Figure 4A</xref>) and by immunoblotting analyses of TIGAR protein in the SCGs (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Similar to the TKO mice, the chTKO mice were also resistant to acute cold exposure compared to the control <italic>Chat<sup>Cre</sup></italic> mice (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Treatment with the SERCA inhibitor CPA, at room temperature (<xref ref-type="fig" rid="fig4">Figure 4D</xref>) or at 4°C (<xref ref-type="fig" rid="fig4">Figure 4E</xref>), also resulted in paralysis and a decline in core body temperature that was not significantly different between the <italic>Chat<sup>Cre</sup></italic> and chTKO mice, although the reduction in core body temperature was much greater at 4°C than at room temperature. The chTKO mice were also resistant to tubocurare at room temperature with both less of a core body temperature drop and a faster recovery (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). In agreement with the TKO mice (<xref ref-type="fig" rid="fig2">Figure 2D</xref>), the resistance to cold-induced hypothermia by acute 4°C challenge was very dramatic in the chTKO mice compared to the control mice (<xref ref-type="fig" rid="fig4">Figure 4G</xref>). Similarly, the chTKO mice were highly resistant to the paralytic actions of tubocurare (<xref ref-type="video" rid="fig4video1">Figure 4—video 1</xref>). Moreover, immunoblotting of the SCG for the neuron activation marker c-Fos further demonstrated that the control mice displayed a small increase in c-Fos protein levels when cold challenged that was further increased in the chTKO mice (<xref ref-type="fig" rid="fig4">Figure 4H</xref>). As controls, there were no significant differences in the protein levels of the vesicular acetylcholine transporter (VAChT) or the plasma membrane choline transporter (ChT) proteins. These data demonstrate that the cholinergic neuron TKO mice recapitulate the cold resistance and pharmacological characteristics of the whole-body TKO mice, consistent with these mice displaying increased cholinergic tone.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Cholinergic neuron-specific TIGAR knockout mice recapitulate the protection against hypothermia of the whole-body TIGAR-deficient mice.</title><p>(<bold>A</bold>) Representative immunofluorescent images showing TIGAR, vesicular acetylcholine transporter (VAChT), and nuclei (DAPI) in the superior cervical ganglions (SCGs) from the control <italic>Chat<sup>Cre</sup></italic> and cholinergic neuron-specific <italic>Tigar</italic> knockout (chTKO) male mice. (<bold>B</bold>) Representative TIGAR, choline acetyltransferase (ChAT), and actin protein immunoblots of the SCG from two independent control <italic>Chat<sup>Cre</sup></italic> and chTKO male mice. (<bold>C</bold>) Male <italic>Chat<sup>Cre</sup></italic> and chTKO mice (n = 6) core body temperatures were measured every 15 min starting at ambient laboratory temperature (0 min) and following placement at 4°C. (<bold>D</bold>) Male <italic>Chat<sup>Cre</sup></italic> and chTKO mice (n = 6) were intraperitoneally injected with cyclopiazonic acid (CPA,10 mg/kg body weight) at room temperature and core body temperature measured every 15 min. (<bold>E</bold>) <italic>Chat<sup>Cre</sup></italic> and chTKO male mice (n = 6) were intraperitoneally injected with CPA (10 mg/kg body weight) at room temperature, shifted to 4°C, and core body temperature measured every 15 min. (<bold>F</bold>) Male <italic>Chat<sup>Cre</sup></italic> and chTKO mice (n = 6) were intraperitoneally injected with tubocurare (0.4 mg/kg body weight), and then core body temperature was measured every 15 min at room temperature. (<bold>G</bold>) <italic>Chat<sup>Cre</sup></italic> and chTKO mice (n = 6) were intraperitoneally injected with tubocurare (0.4 mg/kg body weight) at room temperature and 10 min later shifted to 4°C for 30 min. Core body temperature was measured every 10 minutes. (<bold>H</bold>) Representative TIGAR, c-Fos, VAChT, ChT, and actin protein immunoblots of the SCG from two independent control <italic>Chat<sup>Cre</sup></italic> and chTKO male mice at room temperature or shifted to 4°C for 30 min. Statistical analyses are described in ‘Method details,’ and the data are presented as the mean ± SD. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>The superior cervical ganglion (SCG) tissues were collected and snap-frozen in liquid nitrogen from the <italic>Chat<sup>Cre</sup></italic> and cholinergic neuron-specific <italic>Tigar</italic> knockout (chTKO) mice, as shown in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref> for SCG dissection.</title><p>The SCGs from the three mice of the same strain were pooled and processed by beads homogenization to acquire tissue lysates. 15 μg of the tissue lysate were used for TIGAR (30 kDa) immunoblotting analysis as described in the ‘Immunoblotting’ section. The left four lanes of the raw image (lysate from the mice at ambient temperature) were used for <xref ref-type="fig" rid="fig4">Figure 4B</xref> to confirm the efficiency of TIGAR protein loss in SCG of the chTKO mice. A detailed description of the raw images is shown in <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>.</p></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-73360-fig4-data1-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>The superior cervical ganglion (SCG) tissues were collected and snap-frozen in liquid nitrogen from the <italic>Chat<sup>Cre</sup></italic> and cholinergic neuron-specific <italic>Tigar</italic> knockout (chTKO) mice, as shown in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref> for SCG dissection.</title><p>The SCGs from the three mice of the same strain were pooled and processed by beads homogenization to acquire tissue lysates. 15 μg of the tissue lysate were used for choline acetyltransferase (ChAT, 70 kDa) immunoblotting analysis as described in the ‘Immunoblotting’ section. The left four lanes of the raw image (lysate from the mice at ambient temperature) were used for <xref ref-type="fig" rid="fig4">Figure 4B</xref>. A detailed description of the raw images is shown in <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>.</p></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-73360-fig4-data2-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata3"><label>Figure 4—source data 3.</label><caption><title>The superior cervical ganglion (SCG) tissues were collected and snap-frozen in liquid nitrogen from the <italic>Chat<sup>Cre</sup></italic> and cholinergic neuron-specific <italic>Tigar</italic> knockout (chTKO) mice, as shown in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref> for SCG dissection.</title><p>The SCGs from the three mice of the same strain were pooled and processed by beads homogenization to acquire tissue lysates. 15 μg of the tissue lysate were used for actin β (42 kDa) immunoblotting analysis as described in the ‘Immunoblotting’ section. The left four lanes of the raw image (lysate from the mice at ambient temperature) were used for <xref ref-type="fig" rid="fig4">Figure 4B</xref>. A detailed description of the raw images is shown in <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>.</p></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-73360-fig4-data3-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata4"><label>Figure 4—source data 4.</label><caption><title>The superior cervical ganglion (SCG) tissues were collected and snap-frozen in liquid nitrogen from both ambient temperature housed and 4°C 30 min exposed <italic>Chat<sup>Cre</sup></italic> and cholinergic neuron-specific <italic>Tigar</italic> knockout (chTKO) mice, as shown in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref> for SCG dissection.</title><p>The SCGs from the three mice of the same strain were pooled and processed by beads homogenization to acquire tissue lysates. 15 μg of the tissue lysate were used for TIGAR (30 kDa) immunoblotting analysis as described in the ‘Immunoblotting’ section. The right eight lanes of the raw image (lysate from SCG tissues) was used for <xref ref-type="fig" rid="fig4">Figure 4H</xref> to confirm the efficiency of TIGAR protein loss in SCG of the chTKO mice. The left two lanes of the raw immunoblotting image represent the lysates of soluble fraction (RIPA lysis buffer extracted) of whole-brain tissues from the <italic>Chat<sup>Cre</sup></italic> and chTKO mice, respectively. A detailed description of the raw images is shown in <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>.</p></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-73360-fig4-data4-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata5"><label>Figure 4—source data 5.</label><caption><title>The superior cervical ganglion (SCG) tissues were collected and snap-frozen in liquid nitrogen from both ambient temperature housed and 4°C 30 min exposed <italic>Chat<sup>Cre</sup></italic> and cholinergic neuron-specific <italic>Tigar</italic> knockout (chTKO) mice, as shown in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref> for SCG dissection.</title><p>The SCGs from the three mice of the same strain were pooled and processed by beads homogenization to acquire tissue lysates. 15 μg of the tissue lysate were used for c-Fos (62 kDa) immunoblotting analysis as described in the ‘Immunoblotting’ section. The right eight lanes of the raw image (lysate from SCG tissues) were used for <xref ref-type="fig" rid="fig4">Figure 4H</xref> to show the increase in c-Fos protein in SCG of the chTKO mice under cold exposed. The left two lanes of the raw immunoblotting image represent the lysates of soluble fraction (RIPA lysis buffer extracted) of whole-brain tissues from the <italic>Chat<sup>Cre</sup></italic> and chTKO mice, respectively. A detailed description of the raw images is shown in <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>.</p></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-73360-fig4-data5-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata6"><label>Figure 4—source data 6.</label><caption><title>The superior cervical ganglion (SCG) tissues were collected and snap-frozen in liquid nitrogen from both ambient temperature housed and 4°C 30 min exposed <italic>Chat<sup>Cre</sup></italic> and cholinergic neuron-specific <italic>Tigar</italic> knockout (chTKO) mice, as shown in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref> for SCG dissection.</title><p>The SCGs from the three mice of the same strain were pooled and processed by beads homogenization to acquire tissue lysates. 15 μg of the tissue lysate were used for vesicular acetylcholine transporter (VAChT, 55 kDa) immunoblotting analysis as described in the ‘Immunoblotting’ section. The right eight lanes of the raw image (lysate from SCG tissues) were used for <xref ref-type="fig" rid="fig4">Figure 4H</xref> to show VAChT protein in the SCGs. The left two lanes of the raw immunoblotting image represent the lysates of soluble fraction (RIPA lysis buffer extracted) of whole-brain tissues from the <italic>Chat<sup>Cre</sup></italic> and chTKO mice, respectively. A detailed description of the raw images is shown in <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>.</p></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-73360-fig4-data6-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata7"><label>Figure 4—source data 7.</label><caption><title>The superior cervical ganglion (SCG) tissues were collected and snap-frozen in liquid nitrogen from both ambient temperature housed and 4°C 30 min exposed <italic>Chat<sup>Cre</sup></italic> and cholinergic neuron-specific <italic>Tigar</italic> knockout (chTKO) mice, as shown in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref> for SCG dissection.</title><p>The SCGs from the three mice of the same strain were pooled and processed by beads homogenization to acquire tissue lysates. 15 μg of the tissue lysate were used for choline transporter (ChT, 55 kDa) immunoblotting analysis as described in the ‘Immunoblotting’ section. The right eight lanes of the raw image (lysate from SCG tissues) were used for <xref ref-type="fig" rid="fig4">Figure 4H</xref> to show ChT protein in that 63 and 70 kDa bands were observed in the SCGs. The left two lanes of the raw immunoblotting image represent the lysates of soluble fraction (RIPA lysis buffer extracted) of whole-brain tissues from the <italic>Chat<sup>Cre</sup></italic> and chTKO mice, respectively. A detailed description of the raw images is shown in <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>.</p></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-73360-fig4-data7-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata8"><label>Figure 4—source data 8.</label><caption><title>The superior cervical ganglion (SCG) tissues were collected and snap-frozen in liquid nitrogen from both ambient temperature housed and 4°C 30 min exposed <italic>Chat<sup>Cre</sup></italic> and cholinergic neuron-specific <italic>Tigar</italic> knockout (chTKO) mice, as shown in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref> for SCG dissection.</title><p>The SCGs from the three mice of the same strain were pooled and processed by beads homogenization to acquire tissue lysates. 15 μg of the tissue lysate were used for actin β (42 kDa) immunoblotting analysis as described in the ‘Immunoblotting’ section. The right eight lanes of the raw image (lysate from SCG tissues) were used for <xref ref-type="fig" rid="fig4">Figure 4H</xref> to show actin β protein in the SCGs. The left two lanes of the raw immunoblotting image represent the lysates of soluble fraction (RIPA lysis buffer extracted) of whole-brain tissues from the <italic>Chat<sup>Cre</sup></italic> and chTKO mice, respectively. A detailed description of the raw images is shown in <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>.</p></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-73360-fig4-data8-v2.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73360-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Mouse superior cervical ganglion (SCG) dissection.</title><p>(<bold>A</bold>) The mouse ventral midline of the neck up to the mandible was incised and the salivary glands were exposed. (<bold>B</bold>) The sternocephalicus and posterior belly digastric muscles were retracted after the removal of salivary glands. (<bold>C</bold>) The carotid bifurcation and carotid sheath were identified. (<bold>D</bold>) The SCG behind the carotid sheath was isolated, and the fresh SCGs in two sides were subjected to immunofluorescence imaging and Western blotting experiments for <xref ref-type="fig" rid="fig4">Figure 4</xref>. (<bold>E</bold>) A representative image of SCG from ChAT&lt;Cre&gt; and chTKO, respectively, is shown.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73360-fig4-figsupp1-v2.tif"/></fig><media id="fig4video1" mime-subtype="mp4" mimetype="video" xlink:href="elife-73360-fig4-video1.mp4"><label>Figure 4—video 1.</label><caption><title>Cholinergic neuron-specific <italic>Tigar</italic> knockout (chTKO) mice are resistant to the paralytic effects of tubocurare.</title><p>Representative video clip of the control <italic>Chat<sup>Cre</sup></italic> and chTKO male mice behavior under ambient temperature and at 4°C following intraperitoneal injection of tubocurare (0.4 mg/kg body weight). Rectal temperature recording of <italic>Chat<sup>Cre</sup></italic> and chTKO mice with curare injection was performed on February 7, 2019. The date of birth of both <italic>Chat<sup>Cre</sup></italic> and chTKO mice was October 6, 2018. The body weights of <italic>Chat<sup>Cre</sup></italic> and chTKO were 25.4 g and 27.7 g, respectively. The volume of curare saline solution (0.1 mg/ml in saline) for intraperitoneal (IP) injection was 101.6 µl for the <italic>Chat<sup>Cre</sup></italic> mouse and 110.8 µl for the chTKO mouse. The mice were IP injected with curare, then caged at ambient temperature (21–23°C) for 10 min, and subsequently transferred into a pre-chilled cage in a cold chamber at 4°C for 20 min. The mice were taken back to the cages at ambient temperature (see the sketch below). Rectal temperature was recorded at the time of curare injection and every 10 min thereafter (see the table in the text). The mouse in the left cage is <italic>Chat<sup>Cre</sup></italic>, and the mouse in the right cage is chTKO.</p></caption></media></fig-group><p>If increased cholinergic input is responsible for the increased energy demand and heat production by skeletal muscle, then the skeletal muscle metabolic characteristics of the TKO mice should be recapitulated in the chTKO mice. As shown in <xref ref-type="fig" rid="fig5">Figure 5</xref>, widely targeted LC/MS/MS in the gastrocnemius muscle of the chTKO mice identified the same three key pathways – pentose phosphate pathway, purine nucleotide cycle, and amino acid utilization pathways – that display a greater induction at 4°C. Together, these data are consistent with increased cholinergic signaling to skeletal muscle that is responsible for the increased skeletal muscle thermogenesis following cold exposure.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Skeletal muscles of the cholinergic neuron-specific <italic>Tigar</italic> knockout (chTKO) mice at 4°C display increased pentose phosphate pathway, purine nucleotide cycle, and amino acid utilization pathways.</title><p>The control <italic>Chat<sup>Cre</sup></italic> and chTKO male mice (n = 4–6) were maintained at room temperature (RT) or shifted to 4°C for 1 hr. Quadricep white skeletal muscles were isolated and extracts were subjected to widely targeted (multiple reaction monitoring [MRM]) small metabolite profiling using an ABSciex 6500 + QTRAP with ACE PFP and Merck ZIC-pHILIC columns as described in ‘Materials and methods.’ The heatmap shows the metabolites/pathways differentially identified with the corresponding p-values.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Raw metabolites data were collected in the gastrocnemius muscle of both ambient temperature housed and 4°C 1 hr exposed <italic>Chat<sup>Cre</sup></italic> and cholinergic neuron-specific <italic>Tigar</italic> knockout (chTKO) mice as described in ‘Method details’.</title><p>The data was used in <xref ref-type="fig" rid="fig5">Figure 5</xref>.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73360-fig5-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73360-fig5-v2.tif"/></fig><p>To address the basis of the apparent increase in cholinergic signaling, we first asked whether there was a change in synaptic density in the NMJ. The acetylcholine receptor aggregates in the synaptic cleft and can be specifically labeled with α-bungarotoxin (<xref ref-type="bibr" rid="bib44">Pratt et al., 2018</xref>), as shown for the whole EDL muscle (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Quantification revealed a large degree of heterogeneity in the number of clustered acetylcholine receptors per muscle (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). Nevertheless, there was a clear statistical increase in the TKO mice compared to the control mice. Consistent with the increase in synaptic junctions, the total amount of acetylcholine was also increased in skeletal muscle extracts from the TKO and chTKO mice compared to their respective control mice at both room temperature and after cold exposure (<xref ref-type="fig" rid="fig6">Figure 6C and D</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>TIGAR deficiency increases acetylcholine biosynthesis and acetylcholine receptor clustering at the neuromuscular junction.</title><p>(<bold>A</bold>) Representative images of α-bungarotoxin immunofluorescent labeling of nicotinic acetylcholine receptor clusters in the extensor digitorium longus (EDL) muscle from wild type (WT) and whole-body <italic>Tigar</italic> knockout (TKO) mice. (<bold>B</bold>) Quantification of the number of nicotinic acetylcholine receptor clusters following 15 min exposure at 4°C (WT n = 17, TKO n = 13). These data represent the average of over six mice in each group of mean ± SD (unpaired <italic>t</italic>-test, two-tailed, **p=0.0035). (<bold>C</bold>) Acetylcholine levels in the gastrocnemius muscle of WT and TKO male (n = 7) mice at room temperature or following 1 hr at 4°C. (<bold>D</bold>) Acetylcholine levels in the gastrocnemius muscle of <italic>Chat<sup>Cre</sup></italic> and chTKO male (n = 6) mice at room temperature or following 1 hr at 4°C. (<bold>E</bold>) Representative immunoblots of TIGAR and actin proteins from two scrambled sgRNA and two <italic>Tigar</italic> sgRNA knockout Sh-SY5Y cell lines. (<bold>F</bold>) Acetylcholine concentrations in the medium of scrambled and TKO SH-SH5Y neuroblastoma cells. (<bold>G</bold>) m2 acetylcholine enrichments in cells labeled with <sc>d</sc>-glucose-1,2-<sup>13</sup>C<sub>2.</sub> (<bold>H</bold>) m2 acetylcholine enrichments in cells labeled with U-<sup>13</sup>C<sub>6</sub> <sc>d</sc>-glucose. (<bold>I</bold>) m1 glutamate (<italic>m/z</italic> 128, C2-C4 fragment) enrichment in the medium of scrambled and TKO SH-SY5Y human neuroblastoma cells labeled with <sc>d</sc>-glucose-[1,2]-<sup>13</sup> <sub>C2</sub>. Statistical analyses are described in ‘Method details,’ and the data are presented as the mean ± SD. *p&lt;0.05, ***p&lt;0.001, ****p&lt;0.0001.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>The culture SH-SY5Y cells were collected from both scrambled and whole-body <italic>Tigar</italic> knockout (TKO) cells, and 30 μg of the cell lysates were used for TIGAR (30 kDa) immunoblotting analysis as described in the ‘Immunoblotting’ section.</title><p>The left four lanes of the raw image (lysate from neuroblastoma cells) were used for <xref ref-type="fig" rid="fig6">Figure 6E</xref> to confirm the efficiency of TIGAR protein loss in the SH-SY5Y neuroblastoma TKO cells. The right four lanes of the raw image represent the TIGAR immunoblotting of the cell lysates from 7-day differentiated neuroblastoma cells. A detailed description of the raw images is shown in <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>.</p></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-73360-fig6-data1-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title>The culture SH-SY5Y cells were collected from both scrambled and whole-body <italic>Tigar</italic> knockout (TKO) cells, and 30 μg of the cell lysates were used for actin β (42 kDa) immunoblotting analysis as described in the ‘Immunoblotting’ section.</title><p>The left four lanes of the raw image (lysate from neuroblastoma cells) were used for <xref ref-type="fig" rid="fig6">Figure 6E</xref> to show actin β protein in the SH-SY5Y neuroblastoma cells. The right four lanes of the raw image represent the actin β immunoblotting of the cell lysates from 7-day differentiated neuroblastoma cells. A detailed description of the raw images is shown in <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>.</p></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-73360-fig6-data2-v2.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73360-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Summation of flux results through glycolysis and the TCA cycle using [1,2]–<sup>13</sup>C-glucose by assessing glutamate isotopomers.</title><p>(<bold>A</bold>) [13]-<sup>13</sup>C-glucose becomes [2,3]-<sup>13</sup>C pyruvate if it is directly metabolized through the glycolytic pathway. [2,3]-<sup>13</sup>C-pyruvate can enter the TCA cycle through pyruvate dehydrogenase (PDH) or pyruvate carboxylase (PC). Blue dots indicate <sup>13</sup>C carbons from glucose entering TCA cycle via PDH. Red dots indicate <sup>13</sup>C carbons from glucose entering TCA cycle via PC. (<bold>B</bold>) Representative spectra of the glutamate C2-C4 fragments from TIGAR knockout SH-SY5Y cells labeled with <sc>d</sc>-glucose-[1,2]-<sup>13</sup> <sub>C2</sub>. M0 of the C2-C4 glutamate fragment is <italic>m/z</italic> 128, m1 of glutamate is <italic>m/z</italic> 129 (blue) that indicates the presence of <sup>13</sup>C at the fourth carbon position, and m2 glutamate indicates the presence of <sup>13</sup>C at the second and third carbon positions (red). (<bold>C</bold>) The cellular acetyl-CoA and (<bold>D</bold>) acetyl-carnitine levels in SH-SY5Y cell pellets were measured as described in ‘Method details,’ and the data are presented as the mean ± SD. (<bold>E</bold>) Seahorse flux analyses of oxygen consumption rate (OCR) were performed as described in ‘Method details,’ and the data are presented as the mean ± SEM. Statistical analyses are described in ‘Method details.’ *p&lt;0.05, *<italic>*</italic>p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>Raw metabolites data including cellular acetyl-CoA and acetyl-carnitine were collected from SH-SY5Y control and whole-body <italic>Tigar</italic> knockout (TKO) cell pellet as described in ‘Method details’.</title><p>The data was used in <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73360-fig6-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73360-fig6-figsupp1-v2.tif"/></fig></fig-group><p>As it is not possible to determine the rate of acetylcholine synthesis in vivo, we took advantage of SH-SY5Y cells that have characteristics of cholinergic neurons (<xref ref-type="bibr" rid="bib31">Kovalevich and Langford, 2013</xref>). Using sgRNA and <italic>Cas9</italic>, we effectively knocked out <italic>Tigar</italic> in several clonal SH-SY5Y cells, two representative control, and <italic>sgRNA</italic> knockout cells as shown in <xref ref-type="fig" rid="fig6">Figure 6E</xref>. The amount of acetylcholine secreted into the medium over a 24 hr period was increased in the TKO SH-SY5Y cells compared to controls (<xref ref-type="fig" rid="fig6">Figure 6F</xref>). Labeling with [1,2]-<sup>13</sup>C glucose demonstrates an increase in the m2-labeled acetylcholine levels in the TKO SH-SY5Y cells (<xref ref-type="fig" rid="fig6">Figure 6G</xref>). Similarly, labeling with U-<sup>13</sup>C glucose also demonstrated an increase in m2-labeled acetylcholine in the TKO SH-SY5Y cells (<xref ref-type="fig" rid="fig6">Figure 6H</xref>). Moreover, there was a threefold increase in the enrichment of the C2-C4 fragment, m1-glutamate <italic>m/z</italic> 129, indicating that the acetyl group in acetylcholine originated from glycolysis via pyruvate dehydrogenase (PDH) (<xref ref-type="fig" rid="fig6">Figure 6I</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A and B</xref>). This is because the m2 acetyl group formed via PDH generates <sup>13</sup>C atoms at positions 4 and 5 of glutamate, whereas the m2 <sup>13</sup>C glutamate (<italic>m/z</italic> 130) at positions 2 and 3 is derived from pyruvate carboxylase (PC)-generated oxaloacetate (<xref ref-type="bibr" rid="bib35">Madhu et al., 2020</xref>) schematically shown in <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>. Analyses of the <italic>m/z</italic> 128–130 C2-C4 glutamate fragment distinguish these isotopomers with the enrichment of m1 glutamate (129 fragment) approximately five times more abundant than the m2 glutamate (130 fragment) in the TKO cells (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref>).</p><p>If the changes in glucose flux occurred through increased flux through PDH, then we should also observe a concomitant increase in the levels of acetyl-CoA that is directly generated by PDH from pyruvate. As shown in <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C</xref>, acetyl-CoA levels were increased approximately 1.5-fold and acetyl-carnitine levels approximately 2.5-fold (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1D</xref>). Since acetyl-CoA is converted to acetyl-carnitine in the mitochondria, these demonstrate that <italic>Tigar</italic> deficiency not only increases glycolysis but also results in increased mitochondria uptake of acetyl-CoA (via PDH). The increase in mitochondria PDH flux would in turn drive an increase in oxygen consumption. Seahorse flux analyses of oxygen consumption rate (OCR) clearly demonstrated that the TKO SH-SY5Y cells had higher rates of OCR compared to the control SH-SY5Y cells (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1E</xref>). Together, these data demonstrate that <italic>Tigar</italic> deficiency in SH-SY5Y neuroblastoma cells results from an increase in intracellular acetyl-CoA levels consistent with increased glycolysis and direct conversion of pyruvate to acetyl-CoA by PDH, as opposed to PC. It is the increase in PDH flux into the tricarboxylic acid cycle that drives increased mitochondria oxidation.</p><p>A generalized increased cholinergic tone would be expected to reduce blood pressure and heart rate but with increased skeletal muscle shivering. To assess these physiological parameters, we used implanted telemetry probes to simultaneously determine body temperature, mean arterial pressure (MAP), heart rate (beats per minute [BPM]), and skeletal muscle electromyography (EMG) in the cold-exposed <italic>Chat<sup>Cre</sup></italic> and chTKO mice (<xref ref-type="fig" rid="fig7">Figure 7</xref>). Consistent with the rectal temperature measurements previously observed, the telemetry probe also demonstrated that the chTKO mice are more resistant to cold-induced hypothermia than <italic>Chat<sup>Cre</sup></italic> mice (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). At room temperature, there was no significant difference in blood pressure, but following cold exposure the blood pressure of the control mice increased, whereas the blood pressure of the chTKO mice decreased such that by 60 min the chTKO mice had a blood pressure of 25 mmHg less than the control mice (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). Similarly, the heart rate was not statistically different at room temperature but increased substantially more in the control mice than in the chTKO mice following cold exposure (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). As these data strongly suggest increased cholinergic signaling to enhance skeletal muscle contraction, we utilized EMG to directly determine skeletal muscle activity. A representative image of EMG tracers and root mean square (RMS) derivation is shown for the <italic>Chat<sup>Cre</sup></italic> and chTKO mice when shifted to 4°C for 30 min (<xref ref-type="fig" rid="fig7">Figure 7D</xref>). Quantification of these types of data as the integral of RMS during the time course of cold exposure demonstrated that at room temperature and following 10 min of cold exposure there is no significant difference in skeletal muscle contraction activity between the <italic>Chat<sup>Cre</sup></italic> and chTKO mice (<xref ref-type="fig" rid="fig7">Figure 7E</xref>). However, the contraction activity of the control <italic>Chat<sup>Cre</sup></italic> mice plateau at this level, whereas the chTKO mice shivering activity further increases to nearly twice the level of the control mice.</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>The cholinergic neuron-specific <italic>Tigar</italic> knockout (chTKO) mice display enhanced cold-stimulated skeletal muscle shivering activity and increased cholinergic tone.</title><p>(<bold>A</bold>) Male mice core body temperatures (<italic>Chat<sup>Cre</sup></italic> n = 7, TKO n = 10), (<bold>B</bold>) blood pressure (mmHg) (<italic>Chat<sup>Cre</sup></italic> n = 7, chTKO n = 10), (<bold>C</bold>) heart rate (beats per minute, BPM) (<italic>Chat<sup>Cre</sup></italic> n = 7, chTKO n = 6), (<bold>D</bold>) representative electromyography (EMG) traces and root mean squares (RMS) for <italic>Chat<sup>Cre</sup></italic> and chTKO male mice when shifted to 4°C for 30 min, and (<bold>E</bold>) neck EMG (<italic>Chat<sup>Cre</sup></italic> n = 5, chTKO n = 6) were measured continuously starting at ambient laboratory temperature (0 min) and for 60 min following placement at 4°C. (<bold>F</bold>) Extensor digitorium longus (EDL) muscles from two independent control <italic>Chat<sup>Cre</sup></italic> and chTKO male mice at room temperature (RT) or shifted to 4°C for 1 hr were isolated, and tissue extracts were immunoblotted with an antibody for the phospho-threonine 172 AMPKα subunit (pT172-AMPKα) or total α subunit (AMPKα). Statistical analyses are described in ‘Method details,’ and the data are presented as the mean ± SD. **p&lt;0.01.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>The extensor digitorum longus (EDL) muscles were collected from both ambient temperature housed and 4°C 1 hr exposed <italic>Chat<sup>Cre</sup></italic> and cholinergic neuron-specific <italic>Tigar</italic> knockout (chTKO) mice, and 30 μg of the tissue lysate were used for AMPKα (62 kDa) immunoblotting analysis as described in the ‘Immunoblotting’ section.</title><p>The raw image was used for <xref ref-type="fig" rid="fig7">Figure 7F</xref>. A detailed description of the raw images is shown in <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>.</p></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-73360-fig7-data1-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig7sdata2"><label>Figure 7—source data 2.</label><caption><title>The extensor digitorum longus (EDL) muscles were collected from both ambient temperature housed and 4°C 1 hr exposed <italic>Chat<sup>Cre</sup></italic> and cholinergic neuron-specific <italic>Tigar</italic> knockout (chTKO) mice, and 30 μg of the tissue lysate were used for phospho-<sup>Thr172</sup>AMPKα (62 kDa) immunoblotting analysis as described in the ‘Immunoblotting’ section.</title><p>The raw image was used for <xref ref-type="fig" rid="fig7">Figure 7F</xref>. A detailed description of the raw images is shown in <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>.</p></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-73360-fig7-data2-v2.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73360-fig7-v2.tif"/></fig><p>The increased skeletal muscle shivering associated with increased ATP turnover and energy expenditure would be expected to result in a compensatory increase in AMP-dependent protein kinase (AMPK) activity. As shown in <xref ref-type="fig" rid="fig7">Figure 7F</xref>, there was no significant difference in the activation site phosphorylation (T172) of the AMPK α subunit in the EDL muscle at room temperature between the control <italic>Chat<sup>Cre</sup></italic> and chTKO mice. However, after 1 hr at 4°C, the control mice display the expected increase in T172-AMPKα phosphorylation that was further increased in the chTKO mice. Together, the relative changes in cold--induced blood pressure, heart rate, skeletal muscle shivering, and increase in AMPK activation are fully consistent with the chTKO mice displaying a generalized increase in cholinergic signaling following cold exposure.</p></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Currently, there is a substantial effort to understand and develop approaches to increase energy expenditure through the development/activation of brown/beige adipose tissue thermogenesis. A fraction of adult humans can respond to cold stress by inducing the expression of thermogenic adipose tissue under relatively long-term cold acclimation in adult humans (<xref ref-type="bibr" rid="bib38">McNeill et al., 2021</xref>). However, it remains somewhat controversial if this inducible thermogenic human brown adipose tissue is the rodent equivalent of beige or brown adipocytes (<xref ref-type="bibr" rid="bib11">Cannon et al., 2020</xref>; <xref ref-type="bibr" rid="bib48">Samuelson and Vidal-Puig, 2020</xref>; <xref ref-type="bibr" rid="bib53">Virtanen and Nuutila, 2021</xref>). In addition, whether the mass of the human-inducible thermogenic adipocytes is sufficient to significantly contribute to cold-responsive thermogenesis for core temperature maintenance or weight loss has also been questioned (<xref ref-type="bibr" rid="bib6">Blondin et al., 2014</xref>; <xref ref-type="bibr" rid="bib53">Virtanen and Nuutila, 2021</xref>). In contrast, skeletal muscle accounts for approximately 40% of healthy body mass and is the dominant factor for basal metabolic rate and the major driver of energy expenditure during physical exercise (<xref ref-type="bibr" rid="bib21">Haman et al., 2010</xref>; <xref ref-type="bibr" rid="bib6">Blondin et al., 2014</xref>). In rodents, non-shivering thermogenesis (NST) is driven by UCP1-dependent mitochondrial uncoupling in both brown and beige adipocytes by the creatine phosphorylation/dephosphorylation cycle in beige adipocytes (<xref ref-type="bibr" rid="bib14">Cohen and Spiegelman, 2015</xref>; <xref ref-type="bibr" rid="bib30">Kazak et al., 2015</xref>; <xref ref-type="bibr" rid="bib28">Jung et al., 2019</xref>). There are also reports of a skeletal muscle-based NST via a sarcolipin-dependent futile cycle of SERCA-dependent calcium transport in the sarcoplasmic reticulum (<xref ref-type="bibr" rid="bib4">Bal et al., 2012</xref>; <xref ref-type="bibr" rid="bib37">Maurya et al., 2015</xref>). In humans, maximal NST can increase energy production equivalent to about two times above the resting metabolic rate (RMR), while moderate ST is 2.5–3.5 times RMR and maximal shivering has been measured at about five times RMR (<xref ref-type="bibr" rid="bib21">Haman et al., 2010</xref>; <xref ref-type="bibr" rid="bib6">Blondin et al., 2014</xref>). In contrast, exercise at ~50% VO<sub>2</sub> max generates approximately 15 times RMR (<xref ref-type="bibr" rid="bib56">Weber and Haman, 2005</xref>; <xref ref-type="bibr" rid="bib6">Blondin et al., 2014</xref>). While a substantial effort has focused on NST, shivering and physical activity are the dominant forms of involuntary and voluntary heat production during acute cold exposure. Thus, it is essential to develop a deeper understanding of the physiological integrated role of skeletal muscle with thermogenic adipose tissue to have a complete and detailed molecular understanding of energy balance and its implications for potential interventions to promote and maintain weight loss.</p><p>The data presented in this article demonstrate that cholinergic neuron deficiency of <italic>Tigar</italic> results in an enhancement of cold-induced skeletal muscle contraction/shivering that is responsible for an increase in heat generation and protection of acute cold-induced hypothermia. This response is likely mediated by an increase acetylcholine signaling at the NMJ, consistent with the parallel induction of tubocurare resistance and increased cholinergic neuron activation. Interestingly, despite the increase in synaptic density and acetylcholine levels of mice at room temperature that are mildly cold stress (thermoneutrality for mice is approximately 29–31°C; <xref ref-type="bibr" rid="bib19">Ganeshan and Chawla, 2017</xref>), <italic>Tigar</italic> deficiency does not appear to significantly affect body temperature, skeletal muscle contraction activity, or the overall skeletal muscle metabolite profile at room temperature. However, following acute cold challenge there are marked changes in these parameters between WT and cholinergic TKO mice including a metabolic profile indicative of increased ATP turnover. These findings suggest that there is an increase in cholinergic signaling reserve that only becomes apparent when cholinergic signaling demand is high.</p><p>In addition to the well-established role of sympathetic activation to increase brown and beige adipocytes thermogenesis (<xref ref-type="bibr" rid="bib59">Zhu et al., 2019</xref>), both cholinergic and sympathetic activation can affect vascular blood flow and behavorial activities that also contribute to body temperature regulation (<xref ref-type="bibr" rid="bib41">Nakamura et al., 2022</xref>). Although we cannot rule out the contribution of vasoconstriction to the conservation of core body temperature under cold exposure, heat loss from the mouse tail only accounts for 5–8% of whole-body heat loss (<xref ref-type="bibr" rid="bib50">Skop et al., 2020</xref>) and is therefore unlikely to play a significant role in the thermoregulation observed by cholinergic <italic>Tigar</italic> deficiency.</p><p>In addition to TIGAR as a small carbohydrate phosphatase, previous studies have shown that TIGAR can directly interact with hexokinase 2 and the HOIP subunit of the linear ubiquitin assembly complex (<xref ref-type="bibr" rid="bib12">Cheung et al., 2012</xref>; <xref ref-type="bibr" rid="bib51">Tang et al., 2018</xref>). Thus, although it is formally possible that TIGAR increases cholinergic signaling due to alterations in protein-protein interactions, we believe that it is more likely a result of increased glycolysis due to its phosphatase function that is occurring in the cholinergic neurons as this would result in an increase in acetyl-CoA levels. The steady-state acetyl-CoA concentrations in neuronal mitochondrial and cytosol are several folds lower than the acetyl-CoA Km values for choline acetyltransferase. More specifically, following cholinergic differentiation there is a further decrease in acetyl-CoA levels that results in a further substrate dependence of acetylcholine biosynthesis (<xref ref-type="bibr" rid="bib46">Ronowska et al., 2018</xref>). In contrast, several studies have also shown that choline uptake via the choline transporter is rate limiting for acetylcholine synthesis (<xref ref-type="bibr" rid="bib34">Lockman and Allen, 2002</xref>). Although we have not measured choline uptake activity, <italic>Tigar</italic> deficiency had no significant effect on the amount of choline transporter protein. However, metabolic analyses clearly demonstrated an increased glucose-derived acetyl moiety into acetylcholine and increased steady-state acetylcholine levels with increased acetyl-CoA and acetyl-carnitine levels.</p><p>Thus, the simplest and most direct mechanism for the increase in acetylcholine levels induced by <italic>Tigar</italic> deficiency is the increased formation of acetyl-CoA through enhanced glycolysis, which in turn leads to increased production of acetylcholine in cholinergic neurons. At present, it is not possible to distinguish the amount of synaptic acetyl-CoA from skeletal muscle acetyl-CoA at the NMJ, but future studies using spatial mass spectroscopy (MALDI) may be able to resolve this issue.</p><p>Finally, it is also important to recognize that myasthenia gravis is a neuromuscular disease caused by autoantibodies against components of the NMJ and in particular the nicotinic acetylcholine receptor (<xref ref-type="bibr" rid="bib20">Gilhus et al., 2019</xref>). Current therapeutic strategies are focused on the use of steroids or immune suppressants to block the immune system and drugs to increase the transmission of acetylcholine signaling such as acetylcholine esterase inhibitors (<xref ref-type="bibr" rid="bib20">Gilhus et al., 2019</xref>). Similarly, central cholinergic neurons undergo severe neurodegeneration in Alzheimer’s disease and agents that enhance cholinergic signaling, particularly cholinesterase inhibitor therapies, providing significant symptomatic improvement in patients with Alzheimer’s disease (<xref ref-type="bibr" rid="bib18">Ferreira-Vieira et al., 2016</xref>; <xref ref-type="bibr" rid="bib1">Ahmed et al., 2019</xref>). Interestingly, recent reports show that the NMJs are stable in human age-related sarcopenia and in patients with cancer cachexia, which are different from the rodent models in that the sarcopenia is linked with the endplate fragmentation in NMJ (<xref ref-type="bibr" rid="bib27">Jones et al., 2017</xref>; <xref ref-type="bibr" rid="bib8">Boehm et al., 2020</xref>). As such, inhibition of TIGAR function may also provide a novel approach to improve skeletal muscle function, memory, and dementia through increased cholinergic signaling while limiting the deleterious metabolic consequences secondary to currently available therapies.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background (<italic>Escherichia coli</italic>)</td><td align="left" valign="bottom">Mix &amp; Go Competent Cells-Strain HB10</td><td align="left" valign="bottom">Zymo Research</td><td align="left" valign="bottom">T3013</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Tigar<sup>-/-</sup></italic> (TKO) <break/>(C57BL/6J)</td><td align="left" valign="bottom">PMCID:<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/pmc5961042/">PMC5961042</ext-link></td><td align="left" valign="bottom">MMRRC, Cat# <ext-link ext-link-type="uri" xlink:href="https://www.mmrrc.org/catalog/cellLineSDS.php?mmrrc_id=63577">063577-UCD</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">C57BL/6N-Tigar<sup>tm1b(EUCOMM)Wtsi</sup>/Wtsi</td><td align="left" valign="bottom">Welcome Trust Sanger Institute (Hinxton Cambridge, UK)</td><td align="left" valign="bottom">IMSR Cat# EM:09836;RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_">IMSR_</ext-link> <ext-link ext-link-type="uri" xlink:href="https://www.infrafrontier.eu/search?keyword=EM:09836">EM:09836</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Myl1<sup>Cre</sup>:</italic>Myl1<sup>tm1(cre)Sjb</sup>/J</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_">IMSR_</ext-link><ext-link ext-link-type="uri" xlink:href="https://www.jax.org/strain/024713">JAX:024713</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Chat<sup>Cre</sup>:</italic> B6J.129S6-<italic>Chat<sup>tm2(cre)Lowl</sup></italic>/MwarJ</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_">IMSR_</ext-link> <ext-link ext-link-type="uri" xlink:href="https://www.jax.org/strain/028861">JAX:028861</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Tigar<sup>fl/fl</sup></italic>(C57BL/6J)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Described in ‘Mice models’</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Tigar<sup>fl/fl</sup>Adipoq<sup>Cre</sup></italic> (C57BL/6J)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Described in ‘Mice models’</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Tigar<sup>fl/fl</sup>Myl1<sup>Cre</sup></italic> (C57BL/6J)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Described in ‘Mice models’</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Tigar<sup>fl/fl</sup>/Chat<sup>Cre</sup></italic> (C57BL/6J)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Described in ‘Mice models’</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Ucp1<sup>-/-</sup> (UKO</italic>)(C57BL/6J)</td><td align="left" valign="bottom">Laboratory of Victor L. Schuster</td><td align="left" valign="bottom">Albert Einstein <break/>College of Medicine</td><td align="left" valign="bottom">Described in ‘Mice models’</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Tigar<sup>-/-</sup>/Ucp1<sup>-/-</sup></italic> (UTKO) (C57BL/6J)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Described in ‘Mice models’</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">SH-SY5Y neuroblastoma</td><td align="left" valign="bottom">ATCC</td><td align="left" valign="bottom">ATCC CRL-2266</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">SH-SY5YControl neuroblastoma</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Materials and methods</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">SH-SY5YTIGAR knockout neuroblastoma</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Materials and methods</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-c-Fos (9F6) (rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat# 2250S; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2247211">AB_2247211</ext-link></td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit anti-AMPKα</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat# 2532S; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_330331">AB_330331</ext-link></td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit anti-AMPKα phospho (Thr172)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat# 2535S; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_331250">AB_331250</ext-link></td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-UCP1 (EPR20381) (rabbit monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab209483; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2722676">AB_2722676</ext-link></td><td align="char" char="." valign="bottom">(1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-TIGAR (rabbit polyclonal)</td><td align="left" valign="bottom">Millipore/Sigma</td><td align="left" valign="bottom">Cat# AB10545; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10807181">AB_10807181</ext-link></td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-VChAT (IF) (goat polyclonal)</td><td align="left" valign="bottom">ImmunoStar</td><td align="left" valign="bottom">Cat# 24286; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_572269">AB_572269</ext-link></td><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-VChAT (rabbit polyclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# PA5-95404; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2807207">AB_2807207</ext-link></td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-ChAT (rabbit monoclonal)</td><td align="left" valign="bottom">MilliporeSigma</td><td align="left" valign="bottom">Cat# AB144P; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2079751">AB_2079751</ext-link></td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit anti-choline transporter</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# PA5-77385; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2736619">AB_2736619</ext-link></td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-TIGAR (E-2) (mouse monoclonal)</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Cat# sc-166290; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2066582">AB_2066582</ext-link></td><td align="char" char="." valign="bottom">(1:250)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-TIGAR (E-2) Alexa Fluor 488 (IF) (mouse monoclonal)</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Cat# sc-166290 AF488</td><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 594 donkey anti-goat IgG (H+L)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# A-11058; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2534105">AB_2534105</ext-link></td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-β-actin (C4) (mouse monoclonal)</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Cat# sc-47778; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_626632">AB_626632</ext-link></td><td align="char" char="." valign="bottom">(1:300)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-vinculin (7F9) (mouse monoclonal)</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Cat# sc-73614; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="http://antibodyregistry.org/AB_1131294">AB</ext-link> <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1131294">1131294</ext-link></td><td align="char" char="." valign="bottom">(1:300)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat anti-mouse IgG-HRP</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Cat# sc-2005</td><td align="char" char="." valign="bottom">(1:5000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat anti-rabbit IgG (H+L), HRP</td><td align="left" valign="bottom">Fisher Scientific</td><td align="left" valign="bottom">Cat# PI32460</td><td align="char" char="." valign="bottom">(1:5000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat anti-rabbit 800CW</td><td align="left" valign="bottom">LI-COR</td><td align="left" valign="bottom">Cat#926-32211</td><td align="char" char="." valign="bottom">(1:6000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat anti-mouse 800CW</td><td align="left" valign="bottom">LI-COR</td><td align="left" valign="bottom">Cat#926-32210</td><td align="char" char="." valign="bottom">(1:6000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Donkey anti-goat 800CW</td><td align="left" valign="bottom">LI-COR</td><td align="left" valign="bottom">Cat#926-32214</td><td align="char" char="." valign="bottom">(1:6000)</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">3xsgRNA/Cas9 all-in-one expression clone targeting TIGAR (NM_020375.2)</td><td align="left" valign="bottom">GeneCopoeia</td><td align="left" valign="bottom">Cat#HCP-215394-CG04-3</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">3xsgRNA/Cas9 all-in-one expression clone scrambled sgRNA (control)</td><td align="left" valign="bottom">GeneCopoeia</td><td align="left" valign="bottom">Cat# CCPCTR01-CG04-B</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Tigar<sup>&lt;fl/fl</sup></italic><sup>&gt;</sup> genotyping forward</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">IMSR Cat# HAR:7395; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_HAR:7395">IMSR_HAR:7395</ext-link>(9514-9534)</td><td align="left" valign="bottom">5’-AGGGGGTTG<break/>CACCTCTATCTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Tigar<sup>&lt;fl/fl</sup></italic><sup>&gt;</sup> genotyping reverse</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">IMSR Cat# HAR:7395; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_HAR:7395">IMSR_HAR:7395</ext-link>(16933-16954)</td><td align="left" valign="bottom">5’-CACACAAG<break/>AAGGAAGCTGTTGG</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Direct-zol RNA MiniPrep with 200 ml TRI Reagent</td><td align="left" valign="bottom">Zymo Research</td><td align="left" valign="bottom">Cat# R2053</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">QuickDetect acetylcholine (ACh) (mouse) ELISA Kit</td><td align="left" valign="bottom">BioVision Inc</td><td align="left" valign="bottom">Cat# E4453-100</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">PowerPrep HP Plasmid Maxiprep Kits with Prefilters</td><td align="left" valign="bottom">Origene</td><td align="left" valign="bottom">NP100025</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Ceria Stabilized Zirconium Oxide Beads</td><td align="left" valign="bottom">MidSci</td><td align="left" valign="bottom">Cat# GB01</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">ProLong Gold Antifade Reagent with DAPI</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat# 8961</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">SuperScript IV VILO Master Mix</td><td align="left" valign="bottom">Thermo Fisher Scientific Invitrogen</td><td align="left" valign="bottom">Cat# 11756050</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">TaqMan Universal Master Mix II, no UNG</td><td align="left" valign="bottom">Thermo Fisher Scientific Invitrogen</td><td align="left" valign="bottom">Cat# 4440049</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Tubocurarine hydrochloride pentahydrate</td><td align="left" valign="bottom">Millipore/Sigma</td><td align="left" valign="bottom">Cat# T2379; CAS: 6989-98-6</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Cyclopiazonic acid from <italic>Penicillium cyclopium</italic></td><td align="left" valign="bottom">Millipore/Sigma</td><td align="left" valign="bottom">Cat# C1530; CAS: <ext-link ext-link-type="uri" xlink:href="https://www.sigmaaldrich.com/US/en/search/18172-33-3?focus=products&amp;page=1&amp;perPage=30&amp;sort=relevance&amp;term=18172-33-3&amp;type=cas_number">18172-33-3</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom"><sc>d</sc>-Glucose-1,2-<sup>13</sup>C<sub>2</sub></td><td align="left" valign="bottom">Millipore/Sigma</td><td align="left" valign="bottom">Cat# 453188; CAS: <ext-link ext-link-type="uri" xlink:href="https://www.sigmaaldrich.com/US/en/search/138079-87-5?focus=products&amp;page=1&amp;perPage=30&amp;sort=relevance&amp;term=138079-87-5&amp;type=cas_number">138079-87-5</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom"><sc>d</sc>-Glucose-<sup>13</sup>C<sub>6</sub></td><td align="left" valign="bottom">Millipore/Sigma</td><td align="left" valign="bottom">Cat# 389374; CAS: 110187-42-3</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">MG-132</td><td align="left" valign="bottom">Millipore/Sigma</td><td align="left" valign="bottom">Cat# 474787; CAS: 133407-82-6</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">ALLN</td><td align="left" valign="bottom">Millipore/Sigma</td><td align="left" valign="bottom">Cat# 208719-25MG; <break/>CAS:110044-82-1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">RIPA lysis buffer</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Cat# sc-24948</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Halt Protease and Phosphatase Inhibitor Cocktail</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# 78442</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Pierce Protein-Free T20 (TBS) Blocking Buffer</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# 37571</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">SuperSignal West Pico Chemiluminescent Substrate</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# 34080</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">SuperSignal West Femto Maximum Sensitivity Substrate</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# 34096</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">4% paraformaldehyde solution</td><td align="left" valign="bottom">Electron Microscopy Sciences</td><td align="left" valign="bottom">Cat#RT157-4</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Vectashield Antifade Mounting Medium with DAPI</td><td align="left" valign="bottom">Vector Laboratories, Inc</td><td align="left" valign="bottom">Cat# H1200</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DMEM medium without glucose, glutamine, and sodium pyruvate</td><td align="left" valign="bottom">Biological Industries USA</td><td align="left" valign="bottom">Cat#01-0571-1A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DMEM medium no glucose, glutamine, and sodium pyruvate</td><td align="left" valign="bottom">Biological Industries USA</td><td align="left" valign="bottom">Cat#01-0571-1A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Odyssey Application Software 2.0</td><td align="left" valign="bottom">LI-COR</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GraphPad Prism 8</td><td align="left" valign="bottom">GraphPad Software</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://www.graphpad.com/scientific-software/prism/">http://www.graphpad.com/scientific-software/prism/</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">RQ Manager 1.2.1.</td><td align="left" valign="bottom">Thermo Fisher Scientific Applied Biosystems</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">LD50 Calculator</td><td align="left" valign="bottom">AAT Bioquest</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.aatbio.com/tools/ld50-calculator">https://www.aatbio.com/tools/ld50-calculator</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Velocity software</td><td align="left" valign="bottom">Velocity Software, Inc</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.velocitysoftware.com/">https://www.velocitysoftware.com/</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">MassHunter</td><td align="left" valign="bottom">Agilent Technologies</td><td align="left" valign="bottom">Version: B08.00</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">MultiQuant</td><td align="left" valign="bottom">ABSciex</td><td align="left" valign="bottom">Version: 3.0.2</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">LabChart 8.1 for Macintosh</td><td align="left" valign="bottom">ADInstruments</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.adinstruments.com/products/labchart">https://www.adinstruments.com/products/labchart</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Thermalert Model TH-8 Temperature Monitor</td><td align="left" valign="bottom">Physitemp Instruments LLC.</td><td align="left" valign="bottom">Thermalert Model TH-8</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">HD-X11 telemetric transponder probe</td><td align="left" valign="bottom">DSI, Harvard Bioscience, Inc</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.datasci.com/products/implantable-telemetry/small-animal-telemetry">https://www.datasci.com/products/implantable-telemetry/small-animal-telemetry</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">DSI Implantable Telemetry</td><td align="left" valign="bottom">DSI, Harvard Bioscience, Inc</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.datasci.com/products/implantable-telemetry/small-animal-telemetry">https://www.datasci.com/products/implantable-telemetry/small-animal-telemetry</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">GC-MS instrument</td><td align="left" valign="bottom">Agilent Technologies</td><td align="left" valign="bottom">Model: 5975C</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">DB-5MS column</td><td align="left" valign="bottom">Agilent Technologies</td><td align="left" valign="bottom">Cat#122-5532G</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">LC-MS/MS instrument</td><td align="left" valign="bottom">ABSciex</td><td align="left" valign="bottom">Model: 6500+</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">ZIC-pHILIC column</td><td align="left" valign="bottom">Merck</td><td align="left" valign="bottom">Cat# 1.50460.0001</td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Resource availability</title><sec id="s4-1-1"><title>Lead contact</title><p>Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Jeffrey E Pessin (<ext-link ext-link-type="uri" xlink:href="https://www.einsteinmed.edu/faculty/10953/jeffrey-pessin">Jeffrey.pessin@einsteinmed.edu</ext-link>).</p></sec><sec id="s4-1-2"><title>Materials availability</title><p>This study did not generate new unique reagents. SH-SY5Y neuroblastoma both scrambled and TKO cell lines are available upon request from the lead contact. Mouse lines generated in this study are available from the lead contact, although there are timeline restrictions to the availability of the mice due to the labor and space limitations of the laboratory staff and the facility of the Institution for Animal Studies at Albert Einstein College of Medicine.</p></sec></sec><sec id="s4-2"><title>Experimental models and subject details</title><sec id="s4-2-1"><title>Mice models</title><p>All studies were performed in accordance with protocols approved by the Einstein Institutional Animal Care and Use Committee. TKO mice were used as described in our previous paper (<xref ref-type="bibr" rid="bib51">Tang et al., 2018</xref>). To establish conditional knockout mice of <italic>Tigar</italic> gene, we purchased C57BL/6N-<sup>TIGARtm1b(EUCOMM)Wtsi</sup>/Wtsi mice from the Welcome Trust Sanger Institute (Hinxton Cambridge, UK). Briefly, loxP sites were generated to delete exon 3 of <italic>Tigar</italic>, chimeric mice were mated with C57BL/6mice, and germline transmission was confirmed by PCR and Southern blotting. The progeny crossed sequentially with <italic>FLPe</italic> transgenic mice to remove <italic>lacZ</italic> and <italic>neo</italic> genes. The primer pairs TIGARCKO-5FRT-FW: <named-content content-type="sequence">TTGGGATCCCCTAGTTTGTG</named-content> and TIGARCKO-5FRT-RV: <named-content content-type="sequence">AACTCAGCCTTGAGCCTCTG</named-content> were used to confirm deletion of the <italic>lacZ</italic> and neomycin resistance genes. The primer pairs TIGARCKO-3loxp-FW: <named-content content-type="sequence">GAGAAGAGACCCCCTGGAAC</named-content> and TIGARCKO-3loxp-RV: <named-content content-type="sequence">TTCCGGCCAAACAGACTTAC</named-content> were used to confirm the <italic>Tigar<sup>fl/fl</sup></italic> mice. Mice were backcrossed more than 10 generations to the C57BL/6J mice. The primers for subsequent genotyping for <italic>Tigar<sup>fl/fl</sup></italic> are listed in the Key resources table, and the mouse tail PCR (touchdown cycling protocol, The Jackson Laboratory) results in 538 bp for mutant and 346 bp for the WT mice.</p><p>Adipocyte-specific TKO (<italic>Tigar<sup>fl/fl</sup>/Adipoq<sup>Cre</sup></italic>) mice were produced by mating <italic>Tigar<sup>fl/fl</sup></italic> mice with <italic>Adiponectin-Cre</italic> (<italic>Adipoq<sup>Cre</sup></italic>) mice, as described previously (<xref ref-type="bibr" rid="bib16">Feng et al., 2018</xref>). Skeletal muscle-specific TKO mice were produced by mating the <italic>Tigar<sup>&lt;fl/fl&gt;</sup></italic> mice with skeletal muscle-specific myosin light polypeptide 1 Cre (<italic>Myl1<sup>Cre</sup></italic>) mice purchased from The Jackson Laboratory (stock number 024713). chTKO mice were generated by mating <italic>Tigar<sup>fl/fl</sup></italic> mice with <italic>Chat<sup>Cre</sup></italic> mice purchased from The Jackson Laboratory (stock number 028861). UKO mice, which were C57BL/6J background, were a gift from Dr. Victor Schuster (Albert Einstein College of Medicine). UTKO mice were generated by breeding UKO mice with TKO, which resulted in the production of WT, TKO, UKO, and UTKO mice.</p></sec><sec id="s4-2-2"><title>Mouse husbandry and rectal temperature measurement</title><p>Mice were housed in a facility equipped with a 12 hr light/dark cycle. Animals were fed a normal chow diet that contains 62.3% (kcal) carbohydrates, 24.5% protein, and 13.1% fat (5053, LabDiet). The mice at 12–16 weeks of age were used for rectal temperature measurement using TH-8 Thermometer (Physitemp Instruments, Clifton, NJ) as per the manufacturer’s instructions. For cold exposure, the mouse was individually put into a pre-chilled cage with bedding in a cold chamber (4°C). For tissue collection, the mice were killed, and the tissues were collected and snap-frozen in liquid nitrogen and stored in a −80°C freezer. All studies were approved by and performed in compliance with the guidelines of the Albert Einstein College of Medicine Institutional Animal Care and Use Committee.</p></sec><sec id="s4-2-3"><title>Blood plasma collection</title><p>Mice were briefly anesthetized by isoflurane, and the blood sample was collected from mouse orbital sinus into microtube with EDTA (Microvette 500 K3E, SARSTEDT, Germany) on ice. The plasma sample was collected by centrifugation (1000 × <italic>g</italic>, 30 min) and was stored at –80°C.</p></sec><sec id="s4-2-4"><title>Gastrocnemius and quadricep skeletal muscle samples isolation</title><p>Gastrocnemius and quadricep white muscles were collected and snap-frozen in liquid nitrogen and stored at −80°C. The whole piece of the muscle was ground using a mortar-pestle in liquid nitrogen, and the muscle powder (30 mg) was used for metabolomics analysis.</p></sec><sec id="s4-2-5"><title>Tubocurare and CPA treatments</title><p>Tubocurare (T2379, Sigma-Aldrich) was given as an intraperitoneal injection in a total volume of 100 μl in saline solution reaching at various doses and times indicated in the figure legends, and the median lethal dose (LD<sub>50</sub>) was calculated with LD<sub>50</sub> Calculator, an online tool from AAT Bioquest (Sunnyvale, CA). CPA (C1530, Sigma-Aldrich) was given as an intraperitoneal injection in a total volume of 100 μl in saline solution reaching a dose of 10 mg/kg body weight for the time indicated. In both cases, the same volume of 100 μl of saline were injected as vehicle controls.</p></sec><sec id="s4-2-6"><title>TIGAR knockout in human SH-SY5Y neuroblastoma cells</title><p>Human SH-SY5Y neuroblastoma cell line was purchased from ATCC (ATCC CRL-2266). The SH-SY5Y cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum and 1× penicillin-streptomycin. Cell lines were maintained in a 5% CO<sub>2</sub> incubator at 37°C and were routinely tested to exclude <italic>Mycoplasma</italic> contamination.</p><p>The CRISPR <italic>3xsgRNA/Cas9</italic> all-in-one expression clone targeting <italic>Tigar</italic> (NM_020375.2) (Cat# HCP215394-CG04-3) and scrambled sgRNA control for pCRISPR-CG04 (Cat# CCPCTR01-CG04-B) were purchased from GeneCopoeia (Rockville, MD). The plasmid DNAs were transformed and amplified in Mix &amp; Go Competent Cells-Strain HB 101 (Zymo Research, Cat# T3013, Irvine, CA) and purified using PowerPrep HP Plasmid Maxiprep kits with prefilters (Origene, Rockville, MD). The SH-SY5Y neuroblastoma cells were transfected with 10 μg of plasmid DNAs when 60% confluence in 100 mm dishes using transfection reagents GenJet II (SignaGen Laboratories, Rockville, MD) as per the manufacturer’s instructions. The transfected cells were cultured for 48 hr and collected in 500 μl of MACS buffer (phosphate-buffered saline [PBS-containing EDTA]) containing 1% fetal bovine serum in Falcon 5 ml polystyrene round-bottom tube filtered with a cell-strainer cap. The GFP-positive cells were selected using FACS GFP sorting and were cultured and proliferated in 10% FBS DMEM. The cell descent was collected, and cell lysate was immunoblotted with a TIGAR antibody.</p></sec></sec><sec id="s4-3"><title>Method details</title><sec id="s4-3-1"><title>In vivo <sup>18</sup>O isotopic labeling of cellular phosphoryls of quardricep white muscle of the mice</title><p>WT and TKO male mice (n = 3–4 per condition) were kept at room temperature or shifted to 4°C for 1 hr and then given an oral gavage of 0.3 ml pure H<sub>2</sub><sup>18</sup>O for 10 min at 4°C and an IP injection of 1 ml saline H<sub>2</sub><sup>18</sup>O (0.9% NaCl in <sup>18</sup>O water) for another 10 min at 4<sup>o</sup>C. The dosing and timing of this protocol were selected from pilot studies to ensure steady-state labeling of the ATP pool. The quadricep muscles were freeze-clamped with liquid N<sub>2</sub> and extracts prepared for mass spectroscopic analyses for the identification of the position of <sup>18</sup>O into the phosphates of ATP, which can be extrapolated to ADP and AMP (<xref ref-type="bibr" rid="bib42">Nemutlu et al., 2015</xref>).</p></sec><sec id="s4-3-2"><title>Purification and isotopic analysis of <sup>18</sup>O-labeled cellular phosphoryls</title><p>Quadricep muscles were freeze-clamped and pulverized in mortar with liquid nitrogen, and extracted in 80% methanol solution. The samples were centrifuged at 10,500 rpm for 10 min at 4°C to precipitate proteins. The supernatants were transferred to an LCMS sampling vial pending for injection. Metabolite separation was performed on a ZIC-pHILIC column (Merck). Data was collected with ABSciex 6500 + QTRAP MS/MS with a multiple reaction monitoring (MRM) mode. The ions monitored are listed as follows:</p><table-wrap id="inlinetable1" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Metabolites</th><th align="left" valign="bottom">Isotope labels</th><th align="left" valign="bottom">Q1</th><th align="left" valign="bottom">Q3</th></tr></thead><tbody><tr><td align="left" valign="bottom">AMP</td><td align="left" valign="bottom">M0</td><td align="char" char="." valign="bottom">346</td><td align="char" char="." valign="bottom">79</td></tr><tr><td align="left" valign="bottom">AMP</td><td align="left" valign="bottom">M2</td><td align="char" char="." valign="bottom">348</td><td align="char" char="." valign="bottom">81</td></tr><tr><td align="left" valign="bottom">AMP</td><td align="left" valign="bottom">M4</td><td align="char" char="." valign="bottom">250</td><td align="char" char="." valign="bottom">83</td></tr><tr><td align="left" valign="bottom">ADP</td><td align="left" valign="bottom">M0</td><td align="char" char="." valign="bottom">426</td><td align="char" char="." valign="bottom">79</td></tr><tr><td align="left" valign="bottom">ADP</td><td align="left" valign="bottom">M2</td><td align="char" char="." valign="bottom">428</td><td align="char" char="." valign="bottom">81</td></tr><tr><td align="left" valign="bottom">ADP</td><td align="left" valign="bottom">M4</td><td align="char" char="." valign="bottom">430</td><td align="char" char="." valign="bottom">83</td></tr><tr><td align="left" valign="bottom">ADP</td><td align="left" valign="bottom">M0</td><td align="char" char="." valign="bottom">426</td><td align="char" char="." valign="bottom">159</td></tr><tr><td align="left" valign="bottom">ADP</td><td align="left" valign="bottom">M2</td><td align="char" char="." valign="bottom">428</td><td align="char" char="." valign="bottom">161</td></tr><tr><td align="left" valign="bottom">ADP</td><td align="left" valign="bottom">M4</td><td align="char" char="." valign="bottom">430</td><td align="char" char="." valign="bottom">163</td></tr><tr><td align="left" valign="bottom">ADP</td><td align="left" valign="bottom">M6</td><td align="char" char="." valign="bottom">432</td><td align="char" char="." valign="bottom">165</td></tr><tr><td align="left" valign="bottom">ATP</td><td align="left" valign="bottom">M0</td><td align="char" char="." valign="bottom">506</td><td align="char" char="." valign="bottom">79</td></tr><tr><td align="left" valign="bottom">ATP</td><td align="left" valign="bottom">M2</td><td align="char" char="." valign="bottom">508</td><td align="char" char="." valign="bottom">81</td></tr><tr><td align="left" valign="bottom">ATP</td><td align="left" valign="bottom">M4</td><td align="char" char="." valign="bottom">510</td><td align="char" char="." valign="bottom">83</td></tr><tr><td align="left" valign="bottom">ATP</td><td align="left" valign="bottom">M0</td><td align="char" char="." valign="bottom">506</td><td align="char" char="." valign="bottom">159</td></tr><tr><td align="left" valign="bottom">ATP</td><td align="left" valign="bottom">M2</td><td align="char" char="." valign="bottom">508</td><td align="char" char="." valign="bottom">161</td></tr><tr><td align="left" valign="bottom">ATP</td><td align="left" valign="bottom">M4</td><td align="char" char="." valign="bottom">510</td><td align="char" char="." valign="bottom">163</td></tr><tr><td align="left" valign="bottom">ATP</td><td align="left" valign="bottom">M6</td><td align="char" char="." valign="bottom">512</td><td align="char" char="." valign="bottom">165</td></tr><tr><td align="left" valign="bottom">ATP</td><td align="left" valign="bottom">M0</td><td align="char" char="." valign="bottom">506</td><td align="char" char="." valign="bottom">239</td></tr><tr><td align="left" valign="bottom">ATP</td><td align="left" valign="bottom">M2</td><td align="char" char="." valign="bottom">508</td><td align="char" char="." valign="bottom">241</td></tr><tr><td align="left" valign="bottom">ATP</td><td align="left" valign="bottom">M4</td><td align="char" char="." valign="bottom">510</td><td align="char" char="." valign="bottom">243</td></tr><tr><td align="left" valign="bottom">ATP</td><td align="left" valign="bottom">M6</td><td align="char" char="." valign="bottom">512</td><td align="char" char="." valign="bottom">245</td></tr><tr><td align="left" valign="bottom">CP</td><td align="left" valign="bottom">M0</td><td align="char" char="." valign="bottom">210</td><td align="char" char="." valign="bottom">79</td></tr><tr><td align="left" valign="bottom">CP</td><td align="left" valign="bottom">M2</td><td align="char" char="." valign="bottom">212</td><td align="char" char="." valign="bottom">81</td></tr><tr><td align="left" valign="bottom">CP</td><td align="left" valign="bottom">M4</td><td align="char" char="." valign="bottom">214</td><td align="char" char="." valign="bottom">83</td></tr></tbody></table></table-wrap><p>The <sup>18</sup>O concentration in mouse body was determined with GC-MS according to the <ext-link ext-link-type="uri" xlink:href="https://www.mmpc.org/shared/document.aspx?id=275&amp;docType=Protocol">MMPC protocol</ext-link>.</p><p>Briefly, 10 µl of plasma from the matched quadricep muscle isolated mice were added to 2 µl of 5 N NaOH and 4 µl of % acetone in acetonitrile to allow for <sup>16</sup>O to <sup>18</sup>O exchange (<xref ref-type="bibr" rid="bib2">Aksnes et al., 1966</xref>). The samples were kept at room temperature overnight (at least 10 hr). After chloroform extraction, the samples were analyzed on an Agilent GC-MS system with EI mode. Selected ion monitoring (SIM scan with ions of 58, 59, and 60) was used for the detection. A linear curve of different percentages (from 0% to 10%) of H<sub>2</sub><sup>18</sup>O in water was prepared along with the samples. <sup>18</sup>O enrichment was calculated with the linear curve. The enrichment of <sup>18</sup>O in phosphates in skeletal muscle (see below) was normalized to the <sup>18</sup>O water enrichment in the plasma.</p></sec></sec><sec id="s4-4"><title>Stable isotope enrichment and acetylcholine analyses in culture media of SH-SY5Y control and TKO neuroblastoma cells</title><p>The SH-SY5Y neuroblastoma cells were cultured in 10 cm dishes until confluent and the culture media were removed, and the cells were washed with DMEM medium (Biological Industries, Boston, Cat# 01-057-1A, without glucose, glutamine, and pyruvate). Ten ml of DMEM containing either 10 mM <sc>d</sc>-glucose-1,2-<sup>13</sup>C<sub>2</sub> (Sigma-Aldrich 453188-1G) or 10 mM <sc>d</sc>-glucose-<sup>13</sup>C6 (U-[<sup>13</sup>C]-glucose) and 10 mM <sc>d</sc>-glucose (unlabeled:labeled = 1:1), 1 mM glutamine, without pyruvate, was added to the cultured cells, and medium was collected at 4, 8, and 24 hr time points. The medium was centrifuged at 1000 × <italic>g</italic> for 20 min at 4°C and stored at –80°C. The plates at 24 hr time point were put on ice and gently rinsed with 1.5 ml of ice-cold 150 mM ammonium acetate. The cells were scraped and transferred into a 2 ml screw cap tube (Cat# 02682558, Thermo Fisher). The cell pellets were collected by 1000 × <italic>g</italic> centrifugation at 4<sup>o</sup>C for 2 min and stored at –80°C for cellular acetyl-CoA and acetyl carnitine measurement.</p><p>Following thawing on ice, the medium was subjected to an ethyl chloroformate (ECF) derivatization according to our developed procedure with a minor modification (<xref ref-type="bibr" rid="bib57">Xie et al., 2007</xref>). Briefly, a volume of 700 µl of cell culture media was added to 500 µl of ethanol:pyridine = 4:1, and 100 µl of ECF. After a brief vortex, the samples were sonicated for 1 min. The derivatized metabolites were extracted with 300 µl of chloroform and injected 1 µl into the GC-MS system in splitless mode (GC-MS, Agilent, USA). Helium was used as a carrier gas at a consistent flow of 1 ml/min. The injection temperature was set at 260°C, and metabolite separation was performed on an Agilent DB-17MS column. The oven program started at 60°C for 0.5 min and rose to 100°C at a rate of 20°C/min, and then to 300°C at a rate of 10°C/min, and then maintained at 300°C for 4.5 min. The data was analyzed with MassHunter Quantitative Analysis software (Agilent).</p><p>The m0 glutamate fragment <italic>m/z</italic> of 128 contains three carbons (carbon 2–4) out of the five carbons, while fragment <italic>m/z</italic> of 202 contains four carbons (carbon 2–5) from the whole glutamate molecule. M1 of glutamate at <italic>m/z</italic> 129 reflects the presence of <sup>13</sup>C at the fourth carbon position. This reflects acetyl units originating from glucose-&gt; pyruvate entering through PDH for eventual oxidation (glycolytic flux for energy generation). M2 of glutamate <italic>m/z</italic> 130 reflects the presence of <sup>13</sup>C at the second and third carbon positions, and reflects pyruvate entering the oxaloacetate pool or through PC (<xref ref-type="bibr" rid="bib35">Madhu et al., 2020</xref>; <xref ref-type="bibr" rid="bib49">Silagi et al., 2020</xref>). M2 of glutamate at 204 is the overall TCA cycle flux. Those two <sup>13</sup>C come from either pyruvate entering from PC or PDH. For lactate, the <italic>m/z</italic> of M0 to M2 for carbon 2 and 3 positions will be 145–147 (<xref ref-type="bibr" rid="bib35">Madhu et al., 2020</xref>). A pooled quality control (QC) sample was injected six times for coefficient of variation (CV) determination. Metabolites with CVs lower than 30% were included for quantification while loss with CVs greater than 30% were considered indeterminant. These data were obtained using a Sciex 6500 + QTRAP with ACE PFP and Merck ZIC-pHILIC columns as described previously (<xref ref-type="bibr" rid="bib25">Hoshino et al., 2012</xref>).</p></sec><sec id="s4-5"><title>Acetylcholine enrichment in culture media of SH-SY5Y control and TKO neuroblastoma cells</title><p>The cell culture medium samples were thawed on ice and 200 µl was added to 800 µl of acetonitrile plus 10 µl of 10 ng/ml acetylecholine_d9 (deuterium 9 as an internal control). The samples were vortex, centrifuged at 14,000 rpm for 10 min, and supernatants were transferred into glass vials. The samples were analyzed with ABSciex 6500 + with ACE PFP column. The MRMs for m0, m1, m2 for acetylcholine and the internal standard are as given in the following table. Data was processed with multiquanta software (ABSciex). The enrichment was calculated after subtracting from the background of the non-labeled treatment samples.</p></sec><sec id="s4-6"><title>MRM table</title><table-wrap id="inlinetable2" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"/><th align="left" valign="bottom"/><th align="left" valign="bottom">Q1 mass (Da)</th><th align="left" valign="bottom">Q3 mass (Da)</th></tr></thead><tbody><tr><td align="char" char="." valign="bottom">1</td><td align="left" valign="bottom">Acetylcholine</td><td align="char" char="." valign="bottom">146.3</td><td align="char" char="." valign="bottom">87.0</td></tr><tr><td align="char" char="." valign="bottom">2</td><td align="left" valign="bottom">Acetylcholine_m1</td><td align="char" char="." valign="bottom">147.3</td><td align="char" char="." valign="bottom">88.0</td></tr><tr><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">Acetylcholine_m2</td><td align="char" char="." valign="bottom">148.3</td><td align="char" char="." valign="bottom">89.0</td></tr><tr><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">(d9) Acetylcholine</td><td align="char" char="." valign="bottom">155.3</td><td align="char" char="." valign="bottom">87.0</td></tr></tbody></table></table-wrap></sec><sec id="s4-7"><title>Cellular acetyl-CoA and acetyl-carnitine measeurement in SH-SY5Y control and TKO neuroblastoma cells</title><p>The cell pellet samples were added with 80% methanol with internal standards (malonyl CoA_<sup>13</sup>C3, and acetyl-carnitine_d3) extraction with three cycles of frozen (liquid nitrogen)-thaw (sonication). The samples were vortex, centrifuged at 21,000 × <italic>g</italic> for 10 min, and the supernatants were transferred into glass vials. The samples were analyzed with ABSciex 6500 + iHILIC-p column (HILICON). Data was processed with multiquanta software (ABSciex).</p></sec><sec id="s4-8"><title>Total RNA extraction and quantitative RT-PCR</title><p>Cellular and tissue total RNA was extracted using TRI reagent and Direct-zol RNA MiniPrep Plus kit (Zymo Research). First-strand cDNA was synthesized using the SuperScript IV VILO cDNA synthesis kit (Thermo Fisher Scientific). TaqMan RT-PCR was performed for the measurement of mRNA using the ΔΔ<italic>C<sub>t</sub></italic> method. Gene expression was adjusted by comparison with <italic>Rpl7</italic> expression. The quantitative RT-PCR results were analyzed with RG Manager version 1.2.1 (Applied Biosystems). Primer-probe mixtures for the genes <italic>Ucp1, Atp2a1 (SERCA1), Atp2a2 (SERCA2), Sln (sarcolipin), Mrln (myoregulin), Chrna1, Chrnb1, Chrnd, Chrne,</italic> and <italic>Chrng</italic> are listed as follows:</p><table-wrap id="inlinetable3" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Gene name</th><th align="left" valign="bottom">Gene name</th><th align="left" valign="bottom">TaqMan assay ID</th></tr></thead><tbody><tr><td align="left" valign="bottom">Uncoupling protein 1 (mitochondrial, proton carrier)</td><td align="left" valign="bottom"><italic>Ucp1</italic></td><td align="left" valign="bottom">Mm01244861_m1</td></tr><tr><td align="left" valign="bottom">ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 (SERCA1)</td><td align="left" valign="bottom"><italic>Atp2a1</italic></td><td align="left" valign="bottom">Mm01275320_m1</td></tr><tr><td align="left" valign="bottom">ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 (SERCA2)</td><td align="left" valign="bottom"><italic>Atp2a2</italic></td><td align="left" valign="bottom">Mm01201431_m1</td></tr><tr><td align="left" valign="bottom">Sarcolipin</td><td align="left" valign="bottom"><italic>Sln</italic></td><td align="left" valign="bottom">Mm00481536_m1</td></tr><tr><td align="left" valign="bottom">Myoregulin</td><td align="left" valign="bottom"><italic>Mrln</italic></td><td align="left" valign="bottom">Mm01175781_m1</td></tr><tr><td align="left" valign="bottom">Cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle)</td><td align="left" valign="bottom"><italic>Chrna1</italic></td><td align="left" valign="bottom">Mm00431629_m1</td></tr><tr><td align="left" valign="bottom">Cholinergic receptor, nicotinic, beta polypeptide 1 (muscle)</td><td align="left" valign="bottom"><italic>Chrnb1</italic></td><td align="left" valign="bottom">Mm00680412_m1</td></tr><tr><td align="left" valign="bottom">Cholinergic receptor, nicotinic, delta polypeptide</td><td align="left" valign="bottom"><italic>Chrnd</italic></td><td align="left" valign="bottom">Mm00445545_m1</td></tr><tr><td align="left" valign="bottom">Cholinergic receptor, nicotinic, epsilon polypeptide</td><td align="left" valign="bottom"><italic>Chrne</italic></td><td align="left" valign="bottom">Mm00437411_m1</td></tr><tr><td align="left" valign="bottom">Cholinergic receptor, nicotinic, gamma polypeptide</td><td align="left" valign="bottom"><italic>Chrng</italic></td><td align="left" valign="bottom">Mm00437419_m1</td></tr></tbody></table></table-wrap><p>Primer-probe mixture for <italic>Rpl7</italic> was customized, and other primer-probe mixtures were obtained from Thermo Fisher Applied Biosystems.</p></sec><sec id="s4-9"><title>Immunoblotting</title><p>Commercial primary antibodies were purchased for the detection of TIGAR (Cat# AB10545, Millipore/Sigma; Cat# sc-677290, Santa Cruz), ChAT (Cat# AB144P, Millipore/Sigma), VAChT (Cat# 24286, ImmunoStar), ChT (Cat# PA5-77385, Thermo Fisher), c-fos (2250S, Cell Signaling; MA5-15055, Invitrogen), phosphor-c-Fos<sup>Ser32</sup> (5348S, Cell Signaling), AMPKα (2532S, Cell Signaling), phospho-threonine 172 AMPKα (2535S, Cell Signaling), UCP1 (ab209483, Abcam), vinculin (sc-73614), and β-actin (sc-47778, Santa Cruz). Samples were prepared from culture cells (washed by cold PBS) or tissues by homogenization with a radioimmune precipitation assay lysis buffer (sc-24948, Santa Cruz Biotechnology) containing Halt protease and phosphatase inhibitor mixture (Cat# 78442, Thermo Fisher Scientific), 100 μ<sc>m</sc> MG132, and 100 μ<sc>m</sc> ALLN (EMD Millipore, Darmstadt, Germany) using Ceria stabilized zirconium oxide beads (MidSci, Valley Park, MO). Homogenates were centrifuged for 15 min at 21,000 × <italic>g</italic> at 4°C, and supernatants were collected for the protein assay using the BCA method. Protein samples were separated by SurePAGE (Bis-Tris) precasted gel (GenScript, Piscataway, NJ) and transferred to nitrocellulose membrane using iBlot Blotting System (Thermo Fisher Scientific). The immunoblot membrane was blocked with Pierce Protein-Free T20 (TBS) blocking buffer (product no. 37571, Thermo Fisher Scientific) and incubated with the first antibody indicated in the blocking buffer. Blots were washed in TBS with Tween 20 (TBST) and incubated with either IRDye 800CW secondary antibody (LI-COR, Lincoln, NE) or horseradish peroxidase-conjugated secondary antibody in blocking buffer. The membrane was washed with TBST and visualized either by the Odyssey Imaging System (LI-COR) or enhanced chemiluminescence (ECL) (Thermo Fisher Scientific Pierce) method. ImageJ was used to quantify protein bands on the membrane.</p></sec><sec id="s4-10"><title>Fluorescence imaging of nicotinic acetylcholine receptors clustering at neuromuscular junctions</title><p>Whole EDL muscles were fixed 30 min with 4% w/v paraformaldehyde after dissection. After PBS washing 5 min × three times, EDL muscles were incubated with 1:1000 dilution of Alexa Fluor 488 conjugate α-Bungarotoxin (Invitrogen B13422) for 2 hr at room temperature, and mounted onto 35 mm glass-bottom dish (MatTek Corporation, Cat# P35G020C.S) with Vectashield Antifade Mounting Medium with DAPI (Cat# H1200, Vector Laboratories, Inc, Burlingame, CA). The NMJ was visualized using a z-series projection on a confocal microscope (Leica SP8) with ×40 objective. Velocity software was used for image analysis.</p></sec><sec id="s4-11"><title>Immunofluorescence imaging of SCG</title><p>The <italic>Chat<sup>Cre</sup></italic> and chTKO male mice (14 weeks old) were euthanized and the fresh SCG tissues were removed (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>) and embedded in optimal cutting temperature compound. The frozen tissue cross-sections (10 μm) were blocked with 3% bovine serum albumin in PBS for 60 min at room temperature. For VChAT and TIGAR immunofluorescence staining, the SCG section was incubated with the mouse monoclonal anti-TIGAR (E-2) Alexa Fluor 488 (sc-166290 AF488, Santa Cruz Biotechnology) and goat polyclonal anti-VChAT (Cat# 24286, ImmunoStar, Hudson, WI) for 2 hr at room temperature. After washing PBS 5 min × three times, Alexa Fluor 594 donkey anti-goat IgG (H+L) (1:1000, Cat# A-11058, Thermo Fisher Scientific) was added to the sections for 30 min at room temperature. The slides were mounted on coverslips with Vectashield Antifade Mounting Medium with DAPI (Cat# H1200, Vector Laboratories, Inc) and visualized using a z-series projection on a confocal microscope (Leica SP8) with ×40 objective.</p></sec><sec id="s4-12"><title>Synchronized measurement of core body temperature, blood pressure, heart beating rate, and electromyography</title><p><italic>Chat<sup>Cre</sup></italic> and chTKO mice were anesthetized with isoflurane and implanted with DSI HD-X11 telemetric transponder probes according to the manufacturer’s guidelines, with the blood pressure probe placed in the descending aorta, the EMG leads run subcutaneously to the neck muscles bilaterally, and the core temperature probe placed intraperitoneally. Animals were returned to a standard temperature housing room maintained at 21–22°C on a 12 hr/12 hr light:dark cycle, lights on at 0700. Mice were individually housed on cob bedding in standard polycarbonate home cages that were placed on telemetric DSI platforms to continuously monitor arterial blood pressure, heart rate, core body temperature, and neck EMG muscle activity from the implanted DSI XD-11 probes using LabChart 8.1 software for Macintosh. After 1 week recovery from surgery, animals’ home cage bedding was removed and replaced by stainless steel mesh flooring 1 inch above the base of the cage. Food but not water was then removed from the home cage, and animals in their home cages on DSI platforms were then placed in a 10' × 10' environmental cold room maintained at 4°C, 35% humidity for 1 hr from 10:00 to 11:00 am, and continuous measurements of heart rate, blood pressure, core temperature, and EMG activity continued. At the end of the 1 hr cold challenge, mice in their individual cages were then returned to the standard temperature housing room, and food and bedding were replaced.</p></sec><sec id="s4-13"><title>Mitochondrial OXPHOS efficiency and capacity</title><p>Respiration of permeabilized muscle fibers was performed as described previously (<xref ref-type="bibr" rid="bib23">Heden et al., 2017</xref>; <xref ref-type="bibr" rid="bib26">Johnson et al., 2018</xref>; <xref ref-type="bibr" rid="bib24">Heden et al., 2019</xref>). Briefly, a small portion of freshly dissected red gastrocnemius muscle tissue was placed in 7.23 mM K<sub>2</sub>EGTA, 2.77 mM Ca K<sub>2</sub>EGTA, 20 mM imidazole, 20 mM taurine, 5.7 mM ATP, 14.3 mM phosphocreatine, 6.56 mM MgCl<sub>2</sub>.6H<sub>2</sub>O, and 50 mM K-MES (pH 7.1). Fiber bundles were separated and permeabilized for 30 min at 4°C with saponin (30 μg/ml) and immediately washed in 105 mM K-MES, 30 mM KCl, 10 mM K<sub>2</sub>HPO<sub>4</sub>, 5 mM MgCl<sub>2</sub>.6H<sub>2</sub>O, BSA (0.5 mg/ml), and 1 mM EGTA (pH 7.4) for 15 min. After washing, high-resolution respiration rates were measured using an OROBOROS Oxygraph-2k.</p></sec><sec id="s4-14"><title>Muscle contraction/relaxation</title><p>The EDL muscle was dissected and tied into the Horizontal Tissue Bath System from Aurora Scientific Inc as described previously (<xref ref-type="bibr" rid="bib17">Ferrara et al., 2018</xref>). The muscles were stimulated with a 20 V twitch train and stretched until optimal length for force production was reached. Muscles were then allowed to equilibrate for 5 min. For force-frequency curves, muscles were stimulated with frequencies ranging from 10 to 200 Hz (0.1 ms pulse, 330 ms train, and 2 min between trains). Forces produced by electrically stimulated muscle contractions were recorded in real time via a force transducer (model 400 A, Aurora Scientific Inc). The specific force was calculated using the cross-sectional area of the muscle tissue (millinewton per square millimeter), as estimated from the weight and length of the muscle.</p></sec><sec id="s4-15"><title>Gastrocnemius muscle acetylcholine assay</title><p>Fresh gastrocnemius muscle was collected and snap-frozen in liquid nitrogen, and the whole piece of the muscle was ground to powder using a mortar-pestle in liquid nitrogen. The muscle powder was then homogenized in PBS (pH 7.4) using Ceria stabilized zirconium oxide beads (MidSci) and the homogenate was centrifuged for 20 min at 3000 rpm at 4°C. The supernatant was collected, and the protein assay was performed using the Pierce BCA Protein Assay kit (Cat# 23225, Thermo Fisher Scientific). The supernatants from different samples were adjusted to the same protein concentration of protein, and the same volume of the supernatants was subjected to acetylcholine assay using QuickDetect acetylcholine (ACh) (mouse) ELISA Kit (Cat# E4453-100, Biovision, Milpitas, CA).</p></sec><sec id="s4-16"><title>Body composition and calorimetry</title><p>Male WT C57BL/6J and TKO mice (n = 4) were internally transferred to the Animal Energy Balance Phenotyping Core of the New York Obesity Research Center at the Albert Einstein College of Medicine. In vivo body composition was determined by magnetic resonance spectroscopy using an ECHOMRI instrument (Echo Medical Systems). The mice were then individually housed in metabolic chambers maintained at 21–22°C on a 12 hr light/12 dark cycle with lights on at 7 am and were provided with a nutritionally complete standard powdered diet (NIH 07) and tap water ad libitum for five consecutive days. Metabolic and behavioral measurements (oxygen consumption, food intake, locomotor activity) were obtained continuously using a CLAMS (Columbus Instruments) open-circuit indirect calorimetry system (<xref ref-type="bibr" rid="bib32">Li et al., 2011</xref>).</p></sec><sec id="s4-17"><title>Measurement of OCR in SH-SY5Y control and TKO neuroblastoma cells</title><p>Real-time OCR was simultaneously assessed in SH-SY5Y control and TKO neuroblastoma cells using a Seahorse Bioscience XF96 extracellular flux analyzer (<xref ref-type="bibr" rid="bib58">Zhang and Zhang, 2019</xref>). Three batches of control CTL (10 wells/batch) and TKO (10 wells/batch) cells, respectively, were performed for the OCR assay. The cell suspension of 5 × 10<sup>4</sup> in 50 μl of DMEM with 10% fetal bovine serum was seeded into a well of the XF 96-well microplates to reach confluence growing an even monolayer. 16 hr later, 200 μl/well of medium were added. The cells were at 95–100% confluence and subjected to Seahorse analysis at the Stable Isotope &amp; Metabolomics Core Facility at the Albert Einstein College of Medicine. Briefly, cells were rinsed and incubated with XF base medium (Agilent, 102353-100) supplemented with 25 mM glucose, 2 mM <sc>l</sc>-glutamine (Thermo Fisher Scientific, 25030081) and 1 mM sodium pyruvate (Thermo Fisher Scientific, 11360070), pH 7.4. After 45 min incubation in a CO<sub>2</sub>-free incubator at 37°C, OCR was recorded at baseline, followed by sequential additions of 1 μM oligomycin (Sigma-Aldrich, 75351), 1 μM FCCP (Sigma-Aldrich, C2920), and 1 μM rotenone (Sigma-Aldrich, R8875). The OCR was automatically recorded and calculated using the Seahorse XF24 software, and the data were exported into Prism 8.1 software for graph production and statistical analysis.</p></sec><sec id="s4-18"><title>Soleus and EDL muscles crossed section HE staining</title><p>Fresh soleus and EDL skeletal muscles from 4-month-old male WT and TKO mice were isolated and fixed in 10% formalin for 48 hr at 4°C. The muscle samples were then switched to 70% alcohol and subjected to H&amp;E staining at the Histology and Comparative Pathology Core at the Albert Einstein College of Medicine. Briefly, fixed muscle samples were embedded in cassettes perpendicularly with paraffin. The block was sectioned 10 µm thick, and the sections were mounted on slides, H&amp;E stained, and covered with clips. The H&amp;E-stained images were captured with a digital microscope camera.</p></sec><sec id="s4-19"><title>Quantification and statistical analyses</title><p>Prism (8.1) GraphPad Software was used for data processing, analyses, and graph productions in the experiments. To analyze the differences of body temperature at different time points among two to four groups of the mice, the tabs of Grouped Analyses/two-way ANOVA (or mixed model)/multiple comparison were selected. The subtab ‘Compare each cell mean with the other cell mean in that row’ was chosen to show the ‘Sidak’s multiple comparison test,’ which summarized the statistical test results. The number of independent experimental replications and the average with standard deviation are provided in the figure legends. Unpaired two-tailed p-value <italic>t</italic>-tests were used for the statistical tests between the two groups. The statistical analyses were made at significance levels as follows: ns, not statistically significant; *p&lt;0.5; **p&lt;0.1; ***p&lt;0.001, and ****p&lt;0.0001.</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Resources, Software, Supervision, Validation, Visualization, Writing – original draft</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Investigation, Methodology, Resources, Software, Validation, Visualization, Writing – original draft</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis, Investigation, Methodology, Resources, Software, Supervision, Validation, Visualization, Writing – original draft</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Investigation, Methodology, Software, Validation, Writing – original draft</p></fn><fn fn-type="con" id="con6"><p>Data curation, Formal analysis, Investigation, Methodology, Resources, Software, Validation, Visualization</p></fn><fn fn-type="con" id="con7"><p>Data curation, Formal analysis, Investigation, Methodology, Resources, Software, Validation</p></fn><fn fn-type="con" id="con8"><p>Data curation, Formal analysis, Investigation, Methodology, Resources, Software, Validation</p></fn><fn fn-type="con" id="con9"><p>Data curation, Formal analysis, Investigation, Methodology, Resources, Software, Validation</p></fn><fn fn-type="con" id="con10"><p>Data curation, Formal analysis, Investigation, Methodology, Resources, Software, Validation</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Resources, Software, Supervision, Validation, Visualization, Writing – original draft</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Resources, Software, Supervision, Validation, Writing – original draft</p></fn><fn fn-type="con" id="con13"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Resources, Software, Supervision, Validation, Writing – original draft</p></fn><fn fn-type="con" id="con14"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All studies were performed in accordance with protocols approved by the Einstein Institutional Animal Care and Use Committee. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (0000-1041, 0000-1061, and 0000-1389) of the Albert Einstein College of Medicine.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-73360-transrepform1-v2.docx"/></supplementary-material><supplementary-material id="sdata1"><label>Source data 1.</label><caption><title>Figure source data and legends.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-73360-data1-v2.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting file; Source Data files have been provided for Figures 1, 3, 4, 5, 7, Figure 1-figure supplement 1, 3, and 6.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Dr. Yu Zhang at the Flow cytometry Core Facility (Albert Einstein College of Medicine) for SH-SY5Y cells FACS sorting. We thank Dr. Xue-liang Du at the Stable Isotope &amp; Metabolomics Core Facility for Seahorse analyses. We also thank Dr. Victor Schuster (Albert Einstein College of Medicine) for the gift of UCP1 knockout mice. We thank Ms. Nicole Fernandez (Ph.D. candidate at the Albert Einstein College of Medicine) for her contribution to the production of Graphic Abstract. This study was supported by grants DK033823 and DK020541 from the National Institutes of Health, and an S10 SIG Award for the Sciex 6500 + QTRAP (1S10OD021798).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>NY</given-names></name><name><surname>Knowles</surname><given-names>R</given-names></name><name><surname>Dehorter</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>New Insights Into Cholinergic Neuron Diversity</article-title><source>Frontiers in Molecular Neuroscience</source><volume>12</volume><elocation-id>204</elocation-id><pub-id pub-id-type="doi">10.3389/fnmol.2019.00204</pub-id><pub-id pub-id-type="pmid">31551706</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aksnes</surname><given-names>G</given-names></name><name><surname>Aksnes</surname><given-names>D</given-names></name><name><surname>Albriktsen</surname><given-names>P</given-names></name><name><surname>von Hofsten</surname><given-names>B</given-names></name><name><surname>Williams</surname><given-names>DH</given-names></name><name><surname>Bunnenberg</surname><given-names>E</given-names></name><name><surname>Djerassi</surname><given-names>C</given-names></name><name><surname>Records</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1966">1966</year><article-title>STUDIES OF THE RATE OF ACID CATALYZED OXYGEN EXCHANGE BETWEEN KETONES AND $sup 18$O-ENRICHED WATER IN ACETONITRILE BY INFRARED ABSORPTION ANALYSIS</article-title><source>Acta Chemica Scandinavica</source><volume>20</volume><fpage>1325</fpage><lpage>1329</lpage><pub-id pub-id-type="doi">10.3891/acta.chem.scand.20-1325</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baird</surname><given-names>MF</given-names></name><name><surname>Graham</surname><given-names>SM</given-names></name><name><surname>Baker</surname><given-names>JS</given-names></name><name><surname>Bickerstaff</surname><given-names>GF</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Creatine-kinase- and exercise-related muscle damage implications for muscle performance and recovery</article-title><source>Journal of Nutrition and Metabolism</source><volume>2012</volume><elocation-id>960363</elocation-id><pub-id pub-id-type="doi">10.1155/2012/960363</pub-id><pub-id pub-id-type="pmid">22288008</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bal</surname><given-names>NC</given-names></name><name><surname>Maurya</surname><given-names>SK</given-names></name><name><surname>Sopariwala</surname><given-names>DH</given-names></name><name><surname>Sahoo</surname><given-names>SK</given-names></name><name><surname>Gupta</surname><given-names>SC</given-names></name><name><surname>Shaikh</surname><given-names>SA</given-names></name><name><surname>Pant</surname><given-names>M</given-names></name><name><surname>Rowland</surname><given-names>LA</given-names></name><name><surname>Bombardier</surname><given-names>E</given-names></name><name><surname>Goonasekera</surname><given-names>SA</given-names></name><name><surname>Tupling</surname><given-names>AR</given-names></name><name><surname>Molkentin</surname><given-names>JD</given-names></name><name><surname>Periasamy</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Sarcolipin is a newly identified regulator of muscle-based thermogenesis in mammals</article-title><source>Nature Medicine</source><volume>18</volume><fpage>1575</fpage><lpage>1579</lpage><pub-id pub-id-type="doi">10.1038/nm.2897</pub-id><pub-id pub-id-type="pmid">22961106</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bensaad</surname><given-names>K</given-names></name><name><surname>Tsuruta</surname><given-names>A</given-names></name><name><surname>Selak</surname><given-names>MA</given-names></name><name><surname>Vidal</surname><given-names>MNC</given-names></name><name><surname>Nakano</surname><given-names>K</given-names></name><name><surname>Bartrons</surname><given-names>R</given-names></name><name><surname>Gottlieb</surname><given-names>E</given-names></name><name><surname>Vousden</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>TIGAR, a p53-inducible regulator of glycolysis and apoptosis</article-title><source>Cell</source><volume>126</volume><fpage>107</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.05.036</pub-id><pub-id pub-id-type="pmid">16839880</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blondin</surname><given-names>DP</given-names></name><name><surname>Tingelstad</surname><given-names>HC</given-names></name><name><surname>Mantha</surname><given-names>OL</given-names></name><name><surname>Gosselin</surname><given-names>C</given-names></name><name><surname>Haman</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Maintaining thermogenesis in cold exposed humans: relying on multiple metabolic pathways</article-title><source>Comprehensive Physiology</source><volume>4</volume><fpage>1383</fpage><lpage>1402</lpage><pub-id pub-id-type="doi">10.1002/cphy.c130043</pub-id><pub-id pub-id-type="pmid">25428848</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blondin</surname><given-names>DP</given-names></name><name><surname>Haman</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Shivering and nonshivering thermogenesis in skeletal muscles</article-title><source>Handb Clin Neurol</source><volume>156</volume><fpage>153</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1016/B978-0-444-63912-7.00010-2</pub-id><pub-id pub-id-type="pmid">30454588</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boehm</surname><given-names>I</given-names></name><name><surname>Miller</surname><given-names>J</given-names></name><name><surname>Wishart</surname><given-names>TM</given-names></name><name><surname>Wigmore</surname><given-names>SJ</given-names></name><name><surname>Skipworth</surname><given-names>RJ</given-names></name><name><surname>Jones</surname><given-names>RA</given-names></name><name><surname>Gillingwater</surname><given-names>TH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Neuromuscular junctions are stable in patients with cancer cachexia</article-title><source>The Journal of Clinical Investigation</source><volume>130</volume><fpage>1461</fpage><lpage>1465</lpage><pub-id pub-id-type="doi">10.1172/JCI128411</pub-id><pub-id pub-id-type="pmid">31794435</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolaños</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>TIGAR’s promiscuity</article-title><source>The Biochemical Journal</source><volume>458</volume><fpage>e5</fpage><lpage>e7</lpage><pub-id pub-id-type="doi">10.1042/BJ20140087</pub-id><pub-id pub-id-type="pmid">24576095</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowman</surname><given-names>WC</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Neuromuscular block</article-title><source>British Journal of Pharmacology</source><volume>147 Suppl 1</volume><fpage>S277</fpage><lpage>S286</lpage><pub-id pub-id-type="doi">10.1038/sj.bjp.0706404</pub-id><pub-id pub-id-type="pmid">16402115</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cannon</surname><given-names>B</given-names></name><name><surname>de Jong</surname><given-names>JMA</given-names></name><name><surname>Fischer</surname><given-names>AW</given-names></name><name><surname>Nedergaard</surname><given-names>J</given-names></name><name><surname>Petrovic</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Human brown adipose tissue: Classical brown rather than brite/beige</article-title><source>Experimental Physiology</source><volume>105</volume><fpage>1191</fpage><lpage>1200</lpage><pub-id pub-id-type="doi">10.1113/EP087875</pub-id><pub-id pub-id-type="pmid">32378255</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>EC</given-names></name><name><surname>Ludwig</surname><given-names>RL</given-names></name><name><surname>Vousden</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mitochondrial localization of TIGAR under hypoxia stimulates HK2 and lowers ROS and cell death</article-title><source>PNAS</source><volume>109</volume><fpage>20491</fpage><lpage>20496</lpage><pub-id pub-id-type="doi">10.1073/pnas.1206530109</pub-id><pub-id pub-id-type="pmid">23185017</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>EC</given-names></name><name><surname>DeNicola</surname><given-names>GM</given-names></name><name><surname>Nixon</surname><given-names>C</given-names></name><name><surname>Blyth</surname><given-names>K</given-names></name><name><surname>Labuschagne</surname><given-names>CF</given-names></name><name><surname>Tuveson</surname><given-names>DA</given-names></name><name><surname>Vousden</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Dynamic ROS Control by TIGAR Regulates the Initiation and Progression of Pancreatic Cancer</article-title><source>Cancer Cell</source><volume>37</volume><fpage>168</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2019.12.012</pub-id><pub-id pub-id-type="pmid">31983610</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>P</given-names></name><name><surname>Spiegelman</surname><given-names>BM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Brown and Beige Fat: Molecular Parts of a Thermogenic Machine</article-title><source>Diabetes</source><volume>64</volume><fpage>2346</fpage><lpage>2351</lpage><pub-id pub-id-type="doi">10.2337/db15-0318</pub-id><pub-id pub-id-type="pmid">26050670</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enerbäck</surname><given-names>S</given-names></name><name><surname>Jacobsson</surname><given-names>A</given-names></name><name><surname>Simpson</surname><given-names>EM</given-names></name><name><surname>Guerra</surname><given-names>C</given-names></name><name><surname>Yamashita</surname><given-names>H</given-names></name><name><surname>Harper</surname><given-names>ME</given-names></name><name><surname>Kozak</surname><given-names>LP</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese</article-title><source>Nature</source><volume>387</volume><fpage>90</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1038/387090a0</pub-id><pub-id pub-id-type="pmid">9139827</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>D</given-names></name><name><surname>Amgalan</surname><given-names>D</given-names></name><name><surname>Singh</surname><given-names>R</given-names></name><name><surname>Wei</surname><given-names>J</given-names></name><name><surname>Wen</surname><given-names>J</given-names></name><name><surname>Wei</surname><given-names>TP</given-names></name><name><surname>McGraw</surname><given-names>TE</given-names></name><name><surname>Kitsis</surname><given-names>RN</given-names></name><name><surname>Pessin</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>SNAP23 regulates BAX-dependent adipocyte programmed cell death independently of canonical macroautophagy</article-title><source>The Journal of Clinical Investigation</source><volume>128</volume><fpage>3941</fpage><lpage>3956</lpage><pub-id pub-id-type="doi">10.1172/JCI99217</pub-id><pub-id pub-id-type="pmid">30102258</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrara</surname><given-names>PJ</given-names></name><name><surname>Verkerke</surname><given-names>ARP</given-names></name><name><surname>Brault</surname><given-names>JJ</given-names></name><name><surname>Funai</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Hypothermia Decreases O2 Cost for Ex Vivo Contraction in Mouse Skeletal Muscle</article-title><source>Medicine and Science in Sports and Exercise</source><volume>50</volume><fpage>2015</fpage><lpage>2023</lpage><pub-id pub-id-type="doi">10.1249/MSS.0000000000001673</pub-id><pub-id pub-id-type="pmid">29787474</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira-Vieira</surname><given-names>TH</given-names></name><name><surname>Guimaraes</surname><given-names>IM</given-names></name><name><surname>Silva</surname><given-names>FR</given-names></name><name><surname>Ribeiro</surname><given-names>FM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Alzheimer’s disease: Targeting the Cholinergic System</article-title><source>Current Neuropharmacology</source><volume>14</volume><fpage>101</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.2174/1570159x13666150716165726</pub-id><pub-id pub-id-type="pmid">26813123</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganeshan</surname><given-names>K</given-names></name><name><surname>Chawla</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Warming the mouse to model human diseases</article-title><source>Nature Reviews. Endocrinology</source><volume>13</volume><fpage>458</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1038/nrendo.2017.48</pub-id><pub-id pub-id-type="pmid">28497813</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilhus</surname><given-names>NE</given-names></name><name><surname>Tzartos</surname><given-names>S</given-names></name><name><surname>Evoli</surname><given-names>A</given-names></name><name><surname>Palace</surname><given-names>J</given-names></name><name><surname>Burns</surname><given-names>TM</given-names></name><name><surname>Verschuuren</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Myasthenia gravis</article-title><source>Nature Reviews. Disease Primers</source><volume>5</volume><elocation-id>30</elocation-id><pub-id pub-id-type="doi">10.1038/s41572-019-0079-y</pub-id><pub-id pub-id-type="pmid">31048702</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haman</surname><given-names>F</given-names></name><name><surname>Blondin</surname><given-names>DP</given-names></name><name><surname>Imbeault</surname><given-names>MA</given-names></name><name><surname>Maneshi</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Metabolic requirements of shivering humans</article-title><source>Frontiers in Bioscience (Scholar Edition)</source><volume>2</volume><fpage>1155</fpage><lpage>1168</lpage><pub-id pub-id-type="doi">10.2741/s124</pub-id><pub-id pub-id-type="pmid">20515847</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatazawa</surname><given-names>Y</given-names></name><name><surname>Senoo</surname><given-names>N</given-names></name><name><surname>Tadaishi</surname><given-names>M</given-names></name><name><surname>Ogawa</surname><given-names>Y</given-names></name><name><surname>Ezaki</surname><given-names>O</given-names></name><name><surname>Kamei</surname><given-names>Y</given-names></name><name><surname>Miura</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Metabolomic Analysis of the Skeletal Muscle of Mice Overexpressing PGC-1α</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0129084</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0129084</pub-id><pub-id pub-id-type="pmid">26114427</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heden</surname><given-names>TD</given-names></name><name><surname>Ryan</surname><given-names>TE</given-names></name><name><surname>Ferrara</surname><given-names>PJ</given-names></name><name><surname>Hickner</surname><given-names>RC</given-names></name><name><surname>Brophy</surname><given-names>PM</given-names></name><name><surname>Neufer</surname><given-names>PD</given-names></name><name><surname>McClung</surname><given-names>JM</given-names></name><name><surname>Funai</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Greater Oxidative Capacity in Primary Myotubes from Endurance-trained Women</article-title><source>Medicine and Science in Sports and Exercise</source><volume>49</volume><fpage>2151</fpage><lpage>2157</lpage><pub-id pub-id-type="doi">10.1249/MSS.0000000000001352</pub-id><pub-id pub-id-type="pmid">28617704</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heden</surname><given-names>T</given-names></name><name><surname>Johnson</surname><given-names>JM</given-names></name><name><surname>Ferrara</surname><given-names>PJ</given-names></name><name><surname>Eshima</surname><given-names>H</given-names></name><name><surname>Verkerke</surname><given-names>ARP</given-names></name><name><surname>Wentzler</surname><given-names>EJ</given-names></name><name><surname>Siripoksup</surname><given-names>P</given-names></name><name><surname>Narowski</surname><given-names>TM</given-names></name><name><surname>Coleman</surname><given-names>CB</given-names></name><name><surname>Lin</surname><given-names>CT</given-names></name><name><surname>Ryan</surname><given-names>TE</given-names></name><name><surname>Reidy</surname><given-names>PT</given-names></name><name><surname>de Castro Brás</surname><given-names>LE</given-names></name><name><surname>Karner</surname><given-names>CM</given-names></name><name><surname>Burant</surname><given-names>CF</given-names></name><name><surname>Maschek</surname><given-names>JA</given-names></name><name><surname>Cox</surname><given-names>JE</given-names></name><name><surname>Mashek</surname><given-names>DG</given-names></name><name><surname>Kardon</surname><given-names>G</given-names></name><name><surname>Boudina</surname><given-names>S</given-names></name><name><surname>Zeczycki</surname><given-names>TN</given-names></name><name><surname>Rutter</surname><given-names>J</given-names></name><name><surname>Shaikh</surname><given-names>SR</given-names></name><name><surname>Vance</surname><given-names>JE</given-names></name><name><surname>Drummond</surname><given-names>MJ</given-names></name><name><surname>Neufer</surname><given-names>PD</given-names></name><name><surname>Funai</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Mitochondrial PE potentiates respiratory enzymes to amplify skeletal muscle aerobic capacity</article-title><source>Science Advances</source><volume>5</volume><elocation-id>eaax8352</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aax8352</pub-id><pub-id pub-id-type="pmid">31535029</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoshino</surname><given-names>A</given-names></name><name><surname>Matoba</surname><given-names>S</given-names></name><name><surname>Iwai-Kanai</surname><given-names>E</given-names></name><name><surname>Nakamura</surname><given-names>H</given-names></name><name><surname>Kimata</surname><given-names>M</given-names></name><name><surname>Nakaoka</surname><given-names>M</given-names></name><name><surname>Katamura</surname><given-names>M</given-names></name><name><surname>Okawa</surname><given-names>Y</given-names></name><name><surname>Ariyoshi</surname><given-names>M</given-names></name><name><surname>Mita</surname><given-names>Y</given-names></name><name><surname>Ikeda</surname><given-names>K</given-names></name><name><surname>Ueyama</surname><given-names>T</given-names></name><name><surname>Okigaki</surname><given-names>M</given-names></name><name><surname>Matsubara</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>p53-TIGAR axis attenuates mitophagy to exacerbate cardiac damage after ischemia</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>52</volume><fpage>175</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2011.10.008</pub-id><pub-id pub-id-type="pmid">22044588</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>JM</given-names></name><name><surname>Ferrara</surname><given-names>PJ</given-names></name><name><surname>Verkerke</surname><given-names>ARP</given-names></name><name><surname>Coleman</surname><given-names>CB</given-names></name><name><surname>Wentzler</surname><given-names>EJ</given-names></name><name><surname>Neufer</surname><given-names>PD</given-names></name><name><surname>Kew</surname><given-names>KA</given-names></name><name><surname>de Castro Brás</surname><given-names>LE</given-names></name><name><surname>Funai</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Targeted overexpression of catalase to mitochondria does not prevent cardioskeletal myopathy in Barth syndrome</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>121</volume><fpage>94</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2018.07.001</pub-id><pub-id pub-id-type="pmid">30008435</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>RA</given-names></name><name><surname>Harrison</surname><given-names>C</given-names></name><name><surname>Eaton</surname><given-names>SL</given-names></name><name><surname>Llavero Hurtado</surname><given-names>M</given-names></name><name><surname>Graham</surname><given-names>LC</given-names></name><name><surname>Alkhammash</surname><given-names>L</given-names></name><name><surname>Oladiran</surname><given-names>OA</given-names></name><name><surname>Gale</surname><given-names>A</given-names></name><name><surname>Lamont</surname><given-names>DJ</given-names></name><name><surname>Simpson</surname><given-names>H</given-names></name><name><surname>Simmen</surname><given-names>MW</given-names></name><name><surname>Soeller</surname><given-names>C</given-names></name><name><surname>Wishart</surname><given-names>TM</given-names></name><name><surname>Gillingwater</surname><given-names>TH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Cellular and Molecular Anatomy of the Human Neuromuscular Junction</article-title><source>Cell Reports</source><volume>21</volume><fpage>2348</fpage><lpage>2356</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.11.008</pub-id><pub-id pub-id-type="pmid">29186674</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>SM</given-names></name><name><surname>Sanchez-Gurmaches</surname><given-names>J</given-names></name><name><surname>Guertin</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Brown Adipose Tissue Development and Metabolism</article-title><source>Handb Exp Pharmacol</source><volume>251</volume><fpage>3</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1007/164_2018_168</pub-id><pub-id pub-id-type="pmid">30203328</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juranek</surname><given-names>JK</given-names></name><name><surname>Wojtkiewicz</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Origins and neurochemical complexity of preganglionic neurons supplying the superior cervical ganglion in the domestic pig</article-title><source>Journal of Molecular Neuroscience</source><volume>55</volume><fpage>297</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1007/s12031-014-0321-8</pub-id><pub-id pub-id-type="pmid">24854048</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kazak</surname><given-names>L</given-names></name><name><surname>Chouchani</surname><given-names>ET</given-names></name><name><surname>Jedrychowski</surname><given-names>MP</given-names></name><name><surname>Erickson</surname><given-names>BK</given-names></name><name><surname>Shinoda</surname><given-names>K</given-names></name><name><surname>Cohen</surname><given-names>P</given-names></name><name><surname>Vetrivelan</surname><given-names>R</given-names></name><name><surname>Lu</surname><given-names>GZ</given-names></name><name><surname>Laznik-Bogoslavski</surname><given-names>D</given-names></name><name><surname>Hasenfuss</surname><given-names>SC</given-names></name><name><surname>Kajimura</surname><given-names>S</given-names></name><name><surname>Gygi</surname><given-names>SP</given-names></name><name><surname>Spiegelman</surname><given-names>BM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A creatine-driven substrate cycle enhances energy expenditure and thermogenesis in beige fat</article-title><source>Cell</source><volume>163</volume><fpage>643</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.09.035</pub-id><pub-id pub-id-type="pmid">26496606</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovalevich</surname><given-names>J</given-names></name><name><surname>Langford</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology</article-title><source>Methods in Molecular Biology (Clifton, N.J.)</source><volume>1078</volume><fpage>9</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1007/978-1-62703-640-5_2</pub-id><pub-id pub-id-type="pmid">23975817</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Camacho</surname><given-names>R</given-names></name><name><surname>Schwartz</surname><given-names>GJ</given-names></name><name><surname>LeRoith</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Intracerebroventricular leptin infusion improves glucose homeostasis in lean type 2 diabetic MKR mice via hepatic vagal and non-vagal mechanisms</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e17058</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0017058</pub-id><pub-id pub-id-type="pmid">21379576</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>QQ</given-names></name><name><surname>Li</surname><given-names>JY</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Qin</surname><given-names>ZH</given-names></name><name><surname>Sheng</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Targeting neuroinflammation to treat cerebral ischemia - the role of TIGAR/NADPH axis</article-title><source>Neurochemistry International</source><volume>148</volume><elocation-id>105081</elocation-id><pub-id pub-id-type="doi">10.1016/j.neuint.2021.105081</pub-id><pub-id pub-id-type="pmid">34082063</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lockman</surname><given-names>PR</given-names></name><name><surname>Allen</surname><given-names>DD</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The transport of choline</article-title><source>Drug Development and Industrial Pharmacy</source><volume>28</volume><fpage>749</fpage><lpage>771</lpage><pub-id pub-id-type="doi">10.1081/ddc-120005622</pub-id><pub-id pub-id-type="pmid">12236062</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madhu</surname><given-names>V</given-names></name><name><surname>Boneski</surname><given-names>PK</given-names></name><name><surname>Silagi</surname><given-names>E</given-names></name><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Kurland</surname><given-names>I</given-names></name><name><surname>Guntur</surname><given-names>AR</given-names></name><name><surname>Shapiro</surname><given-names>IM</given-names></name><name><surname>Risbud</surname><given-names>MV</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Hypoxic Regulation of Mitochondrial Metabolism and Mitophagy in Nucleus Pulposus Cells Is Dependent on HIF-1alpha-BNIP3 Axis</article-title><source>Journal of Bone and Mineral Research</source><volume>35</volume><fpage>1504</fpage><lpage>1524</lpage><pub-id pub-id-type="doi">10.1002/jbmr.4019</pub-id><pub-id pub-id-type="pmid">32251541</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maurya</surname><given-names>SK</given-names></name><name><surname>Periasamy</surname><given-names>M</given-names></name><name><surname>Bal</surname><given-names>NC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>High gender -specific susceptibility to curare- a neuromuscular blocking agent</article-title><source>Biological Research</source><volume>46</volume><fpage>75</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.4067/S0716-97602013000100011</pub-id><pub-id pub-id-type="pmid">23760418</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maurya</surname><given-names>SK</given-names></name><name><surname>Bal</surname><given-names>NC</given-names></name><name><surname>Sopariwala</surname><given-names>DH</given-names></name><name><surname>Pant</surname><given-names>M</given-names></name><name><surname>Rowland</surname><given-names>LA</given-names></name><name><surname>Shaikh</surname><given-names>SA</given-names></name><name><surname>Periasamy</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Sarcolipin Is a Key Determinant of the Basal Metabolic Rate, and Its Overexpression Enhances Energy Expenditure and Resistance against Diet-induced Obesity</article-title><source>The Journal of Biological Chemistry</source><volume>290</volume><fpage>10840</fpage><lpage>10849</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.636878</pub-id><pub-id pub-id-type="pmid">25713078</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNeill</surname><given-names>BT</given-names></name><name><surname>Suchacki</surname><given-names>KJ</given-names></name><name><surname>Stimson</surname><given-names>RH</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>MECHANISMS IN ENDOCRINOLOGY: Human brown adipose tissue as a therapeutic target: warming up or cooling down</article-title><source>European Journal of Endocrinology</source><volume>184</volume><fpage>R243</fpage><lpage>R259</lpage><pub-id pub-id-type="doi">10.1530/EJE-20-1439</pub-id><pub-id pub-id-type="pmid">33729178</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Mor</surname><given-names>I</given-names></name><name><surname>Cheung</surname><given-names>EC</given-names></name><name><surname>Vousden</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Control of glycolysis through regulation of PFK1: old friends and recent additions</article-title><conf-name>Cold Spring Harbor Symposia on Quantitative Biology</conf-name><fpage>211</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1101/sqb.2011.76.010868</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales</surname><given-names>MA</given-names></name><name><surname>Holmberg</surname><given-names>K</given-names></name><name><surname>Xu</surname><given-names>ZQ</given-names></name><name><surname>Cozzari</surname><given-names>C</given-names></name><name><surname>Hartman</surname><given-names>BK</given-names></name><name><surname>Emson</surname><given-names>P</given-names></name><name><surname>Goldstein</surname><given-names>M</given-names></name><name><surname>Elfvin</surname><given-names>LG</given-names></name><name><surname>Hökfelt</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Localization of choline acetyltransferase in rat peripheral sympathetic neurons and its coexistence with nitric oxide synthase and neuropeptides</article-title><source>PNAS</source><volume>92</volume><fpage>11819</fpage><lpage>11823</lpage><pub-id pub-id-type="doi">10.1073/pnas.92.25.11819</pub-id><pub-id pub-id-type="pmid">8524856</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Kataoka</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>A hypothalamomedullary network for physiological responses to environmental stresses</article-title><source>Nature Reviews. Neuroscience</source><volume>23</volume><fpage>35</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1038/s41583-021-00532-x</pub-id><pub-id pub-id-type="pmid">34728833</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nemutlu</surname><given-names>E</given-names></name><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Viqar</surname><given-names>M</given-names></name><name><surname>Holmuhamedov</surname><given-names>E</given-names></name><name><surname>Terzic</surname><given-names>A</given-names></name><name><surname>Jahangir</surname><given-names>A</given-names></name><name><surname>Dzeja</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Decline of Phosphotransfer and Substrate Supply Metabolic Circuits Hinders ATP Cycling in Aging Myocardium</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0136556</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0136556</pub-id><pub-id pub-id-type="pmid">26378442</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okawa</surname><given-names>Y</given-names></name><name><surname>Hoshino</surname><given-names>A</given-names></name><name><surname>Ariyoshi</surname><given-names>M</given-names></name><name><surname>Kaimoto</surname><given-names>S</given-names></name><name><surname>Tateishi</surname><given-names>S</given-names></name><name><surname>Ono</surname><given-names>K</given-names></name><name><surname>Uchihashi</surname><given-names>M</given-names></name><name><surname>Iwai-Kanai</surname><given-names>E</given-names></name><name><surname>Matoba</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Ablation of cardiac TIGAR preserves myocardial energetics and cardiac function in the pressure overload heart failure model</article-title><source>American Journal of Physiology. Heart and Circulatory Physiology</source><volume>316</volume><fpage>H1366</fpage><lpage>H1377</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00395.2018</pub-id><pub-id pub-id-type="pmid">30901275</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pratt</surname><given-names>SJP</given-names></name><name><surname>Iyer</surname><given-names>SR</given-names></name><name><surname>Shah</surname><given-names>SB</given-names></name><name><surname>Lovering</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Imaging Analysis of the Neuromuscular Junction in Dystrophic Muscle</article-title><source>Methods in Molecular Biology (Clifton, N.J.)</source><volume>1687</volume><fpage>57</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-7374-3_5</pub-id><pub-id pub-id-type="pmid">29067656</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rigden</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The histidine phosphatase superfamily: structure and function</article-title><source>The Biochemical Journal</source><volume>409</volume><fpage>333</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1042/BJ20071097</pub-id><pub-id pub-id-type="pmid">18092946</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronowska</surname><given-names>A</given-names></name><name><surname>Szutowicz</surname><given-names>A</given-names></name><name><surname>Bielarczyk</surname><given-names>H</given-names></name><name><surname>Gul-Hinc</surname><given-names>S</given-names></name><name><surname>Klimaszewska-Łata</surname><given-names>J</given-names></name><name><surname>Dyś</surname><given-names>A</given-names></name><name><surname>Zyśk</surname><given-names>M</given-names></name><name><surname>Jankowska-Kulawy</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The Regulatory Effects of Acetyl-CoA Distribution in the Healthy and Diseased Brain</article-title><source>Frontiers in Cellular Neuroscience</source><volume>12</volume><elocation-id>169</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2018.00169</pub-id><pub-id pub-id-type="pmid">30050410</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>J</given-names></name><name><surname>Balthasar</surname><given-names>N</given-names></name><name><surname>Olson</surname><given-names>D</given-names></name><name><surname>Scott</surname><given-names>M</given-names></name><name><surname>Berglund</surname><given-names>E</given-names></name><name><surname>Lee</surname><given-names>CE</given-names></name><name><surname>Choi</surname><given-names>MJ</given-names></name><name><surname>Lauzon</surname><given-names>D</given-names></name><name><surname>Lowell</surname><given-names>BB</given-names></name><name><surname>Elmquist</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Melanocortin-4 receptors expressed by cholinergic neurons regulate energy balance and glucose homeostasis</article-title><source>Cell Metabolism</source><volume>13</volume><fpage>195</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2011.01.010</pub-id><pub-id pub-id-type="pmid">21284986</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samuelson</surname><given-names>I</given-names></name><name><surname>Vidal-Puig</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Studying Brown Adipose Tissue in a Human in vitro Context</article-title><source>Frontiers in Endocrinology</source><volume>11</volume><elocation-id>629</elocation-id><pub-id pub-id-type="doi">10.3389/fendo.2020.00629</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silagi</surname><given-names>ES</given-names></name><name><surname>Novais</surname><given-names>EJ</given-names></name><name><surname>Bisetto</surname><given-names>S</given-names></name><name><surname>Telonis</surname><given-names>AG</given-names></name><name><surname>Snuggs</surname><given-names>J</given-names></name><name><surname>Le Maitre</surname><given-names>CL</given-names></name><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Kurland</surname><given-names>IJ</given-names></name><name><surname>Shapiro</surname><given-names>IM</given-names></name><name><surname>Philp</surname><given-names>NJ</given-names></name><name><surname>Risbud</surname><given-names>MV</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Lactate Efflux From Intervertebral Disc Cells Is Required for Maintenance of Spine Health</article-title><source>Journal of Bone and Mineral Research</source><volume>35</volume><fpage>550</fpage><lpage>570</lpage><pub-id pub-id-type="doi">10.1002/jbmr.3908</pub-id><pub-id pub-id-type="pmid">31692093</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skop</surname><given-names>V</given-names></name><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Gavrilova</surname><given-names>O</given-names></name><name><surname>Reitman</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The contribution of the mouse tail to thermoregulation is modest</article-title><source>American Journal of Physiology. Endocrinology and Metabolism</source><volume>319</volume><fpage>E438</fpage><lpage>E446</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00133.2020</pub-id><pub-id pub-id-type="pmid">32691633</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Kwon</surname><given-names>H</given-names></name><name><surname>Neel</surname><given-names>BA</given-names></name><name><surname>Kasher-Meron</surname><given-names>M</given-names></name><name><surname>Pessin</surname><given-names>JB</given-names></name><name><surname>Yamada</surname><given-names>E</given-names></name><name><surname>Pessin</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The fructose-2,6-bisphosphatase TIGAR suppresses NF-kappaB signaling by directly inhibiting the linear ubiquitin assembly complex LUBAC</article-title><source>The Journal of Biological Chemistry</source><volume>293</volume><fpage>7578</fpage><lpage>7591</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA118.002727</pub-id><pub-id pub-id-type="pmid">29650758</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Qin</surname><given-names>ZH</given-names></name><name><surname>Sheng</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Structure, regulation, and biological functions of TIGAR and its role in diseases</article-title><source>Acta Pharmacologica Sinica</source><volume>42</volume><fpage>1547</fpage><lpage>1555</lpage><pub-id pub-id-type="doi">10.1038/s41401-020-00588-y</pub-id><pub-id pub-id-type="pmid">33510458</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Virtanen</surname><given-names>KA</given-names></name><name><surname>Nuutila</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The importance of human brown adipose tissue volume</article-title><source>Nature Reviews. Endocrinology</source><volume>17</volume><fpage>453</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1038/s41574-021-00522-0</pub-id><pub-id pub-id-type="pmid">34117463</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>FZ</given-names></name><name><surname>Nelson</surname><given-names>PG</given-names></name><name><surname>Fitzgerald</surname><given-names>SC</given-names></name><name><surname>Hersh</surname><given-names>LB</given-names></name><name><surname>Neale</surname><given-names>EA</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Cholinergic function in cultures of mouse spinal cord neurons</article-title><source>Journal of Neuroscience Research</source><volume>25</volume><fpage>312</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1002/jnr.490250307</pub-id><pub-id pub-id-type="pmid">2325157</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Myles</surname><given-names>RC</given-names></name><name><surname>Lee</surname><given-names>IJ</given-names></name><name><surname>Bers</surname><given-names>DM</given-names></name><name><surname>Ripplinger</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Role of Reduced Sarco-Endoplasmic Reticulum Ca(2+)-ATPase Function on Sarcoplasmic Reticulum Ca(2+) Alternans in the Intact Rabbit Heart</article-title><source>Frontiers in Physiology</source><volume>12</volume><elocation-id>656516</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2021.656516</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>JM</given-names></name><name><surname>Haman</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Fuel selection in shivering humans</article-title><source>Acta Physiologica Scandinavica</source><volume>184</volume><fpage>319</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1111/j.1365-201X.2005.01465.x</pub-id><pub-id pub-id-type="pmid">16026423</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>GX</given-names></name><name><surname>Qiu</surname><given-names>YP</given-names></name><name><surname>Qiu</surname><given-names>MF</given-names></name><name><surname>Gao</surname><given-names>XF</given-names></name><name><surname>Liu</surname><given-names>YM</given-names></name><name><surname>Jia</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Analysis of dencichine in Panax notoginseng by gas chromatography-mass spectrometry with ethyl chloroformate derivatization</article-title><source>Journal of Pharmaceutical and Biomedical Analysis</source><volume>43</volume><fpage>920</fpage><lpage>925</lpage><pub-id pub-id-type="doi">10.1016/j.jpba.2006.09.009</pub-id><pub-id pub-id-type="pmid">17029672</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Using Seahorse Machine to Measure OCR and ECAR in Cancer Cells</article-title><source>Methods in Molecular Biology (Clifton, N.J.)</source><volume>1928</volume><fpage>353</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-9027-6_18</pub-id><pub-id pub-id-type="pmid">30725464</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Q</given-names></name><name><surname>Glazier</surname><given-names>BJ</given-names></name><name><surname>Hinkel</surname><given-names>BC</given-names></name><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Liang</surname><given-names>C</given-names></name><name><surname>Shi</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Neuroendocrine Regulation of Energy Metabolism Involving Different Types of Adipose Tissues</article-title><source>International Journal of Molecular Sciences</source><volume>20</volume><elocation-id>11</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20112707</pub-id><pub-id pub-id-type="pmid">31159462</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.73360.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Elmquist</surname><given-names>Joel K</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00t9vx427</institution-id><institution>University of Texas Southwestern Medical Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" link-type="continued-by" object-id="10.1101/2021.09.28.462124" object-id-type="id" xlink:href="https://sciety.org/articles/activity/10.1101/2021.09.28.462124"/></front-stub><body><p>The authors report results from timely studies, demonstrating the role of TIGAR in regulating thermoregulation. Deletion of TIGAR leads to resistance to cold-induced hypothermia. The results will be of wide interest.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.73360.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Elmquist</surname><given-names>Joel K</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00t9vx427</institution-id><institution>University of Texas Southwestern Medical Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Saltiel</surname><given-names>Alan</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0168r3w48</institution-id><institution>UCSD</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.09.28.462124">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.09.28.462124v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Neuronal glucose metabolism sets cholinergic tone and controls thermo-regulated signaling at the neuromuscular junction&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Ma-Li Wong as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Alan Saltiel (Reviewer #2).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) Report body weights and body composition to exclude contributions from increased muscle mass. Metabolic cage data would eliminate alterations in physical activity, food consumption and basal energy expenditure as factors that protect from cold exposure.</p><p>2) Either provide data to support increased metabolic rates in the cell model (i.e. VO2, kinetic enrichment data, etc.) or reword the few discussion points that imply increased acetyl-CoA rates of production from glycolysis drive the cholinergic effect. As a side point, acetyl-CoA concentration could be measured in the cell model.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>Can the authors explained what they mean by &quot;since UCP1 protein levels lag mRNA expression there was no detectable UCP1 protein&quot; in iWAT. Could it be that there just isn't detectable amount of protein there?</p><p>Authors indicate that both UKO and TKO mice were &quot;both with C57BL/6J background (line 128) but methods indicate that UKO were on C57BL/6N background.</p><p>Loading controls are missing for Figure 1G.</p><p>Figure 4A's resolution is too low to be convincing.</p><p>Line 149: Figure S1G rather than 1G.</p><p>Statistical analysis: please describe two-way ANOVA multiple comparisons (what post-hoc tests were conducted when there was significant interactions/main effects?).</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>This interesting manuscript entitled &quot;Neuronal glucose metabolism sets cholinergic tone and controls thermo-regulated signaling at the neuromuscular junction&quot; reports the surprising finding that TIGER knockout mice are resistant to cold challenge because of alterations to cholinergic neurons. The study is well executed, clearly written and describes a logical progression of the discovery that TIGER in cholinergic neurons is responsible for the resistance to cold in whole body knockout mice. Sophisticated metabolite profiling is used to determine cholinergic neurons and in vitro SH-SY5Y neurons have increased glycolysis in the absence of TIGER, and further that this loss of TIGER in cholinergic neurons has important physiological consequences for muscle function and shivering thermogenesis.</p><p>I have only a few marginal comments that the author may wish to consider.</p><p>Comment on which cholinergic neurons are responsible for the cold resistance in TIGER knockout mice, peripheral or central?</p><p>Central NFkB has an important role in neuronal dendrite growth. Can you rule out NFkB signaling as a contributing factor to enhanced cold tolerance in the TIGER knockout mice?</p><p>There are far too many &quot;data not shown&quot; comments in the paper; please show the data in the supplement (lines 99, 113, 119, 159, 168 and 221).</p><p>While acetylcholine production relies heavily on acetyl-CoA availability, another important rate limiting step is the availability of choline controlled by the choline pump on the postsynaptic terminal after acetylcholine is degraded in the junction. This could be the rate limiting step during shivering thermogenesis or exercise. Did you assess expression of this transporter in the mouse models?</p><p>TIGER cholinergic neuron specific knockout and whole-body knockout should also have differences in exercise capacity and grip strength. Did the authors assess these physical parameters?</p><p>Was there a difference in muscle weights, fiber type or myotube diameter in the TIGER knockout mouse models?<italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>Was media lactate enrichment examined?</p><p>Provide a more complete description of the H218O study. Was the enrichment data normalized to body water enrichment? If not, please point that out and provide justification (e.g. were the mice body weight and composition matched?). Why was water administered by gavage and IP? The IP water injection is quite a large volume. Was it administered as a saline solution? If not, please justify (i.e. can a pain response be excluded?). How was the timing of the tissue collection chosen? Is this timing indicative steady state ATP turnover, or is it closer to an initial rate?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.73360.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Report body weights and body composition to exclude contributions from increased muscle mass. Metabolic cage data would eliminate alterations in physical activity, food consumption and basal energy expenditure as factors that protect from cold exposure.</p></disp-quote><p>We now include lean/fat mass, activity, food consumption and basal energy expenditure in new Figure 1—figure supplement 1 D, F, G and H. We also include skeletal muscle histology in new Figure 1—figure supplement 1 E.</p><disp-quote content-type="editor-comment"><p>2) Either provide data to support increased metabolic rates in the cell model (i.e. VO2, kinetic enrichment data, etc.) or reword the few discussion points that imply increased acetyl-CoA rates of production from glycolysis drive the cholinergic effect. As a side point, acetyl-CoA concentration could be measured in the cell model.</p></disp-quote><p>We have included the oxygen consumption rate (new Figure 6—figure supplement E) and have determined acetyl-CoA and acetyl-carnitine levels presented in new Figure 6—figure supplement C and D.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>Can the authors explained what they mean by &quot;since UCP1 protein levels lag mRNA expression there was no detectable UCP1 protein&quot; in iWAT. Could it be that there just isn't detectable amount of protein there?</p></disp-quote><p>The statement “since UCP1 protein levels lag mRNA…..etc..” was intended exactly as you indicated, that we could not measure any change in UCP1 protein although at this time point there was a measurable increase in UCP1 mRNA. This unclear statement has now been removed from the text.</p><disp-quote content-type="editor-comment"><p>Authors indicate that both UKO and TKO mice were &quot;both with C57BL/6J background (line 128) but methods indicate that UKO were on C57BL/6N background.</p></disp-quote><p>The background strain for the UKO mice was C57BL/6J</p><disp-quote content-type="editor-comment"><p>Loading controls are missing for Figure 1G.</p></disp-quote><p>The loading control for Figure 1 G is now included.</p><disp-quote content-type="editor-comment"><p>Figure 4A's resolution is too low to be convincing.</p></disp-quote><p>We have increased the resolution of Figure 4 A. The difficulty in visualization is the size of the image due to space limitations. If you enlarge the image the differences are readily apparent.</p><disp-quote content-type="editor-comment"><p>Line 149: Figure S1G rather than 1G.</p></disp-quote><p>Figure S1G rather the 1 G has been corrected.</p><disp-quote content-type="editor-comment"><p>Statistical analysis: please describe two-way ANOVA multiple comparisons (what post-hoc tests were conducted when there was significant interactions/main effects?).</p></disp-quote><p>We have provided a detailed description of the statistical tests in the Method details section. We also have modified the description of statistical test in the figure legends.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>This interesting manuscript entitled &quot;Neuronal glucose metabolism sets cholinergic tone and controls thermo-regulated signaling at the neuromuscular junction&quot; reports the surprising finding that TIGER knockout mice are resistant to cold challenge because of alterations to cholinergic neurons. The study is well executed, clearly written and describes a logical progression of the discovery that TIGER in cholinergic neurons is responsible for the resistance to cold in whole body knockout mice. Sophisticated metabolite profiling is used to determine cholinergic neurons and in vitro SH-SY5Y neurons have increased glycolysis in the absence of TIGER, and further that this loss of TIGER in cholinergic neurons has important physiological consequences for muscle function and shivering thermogenesis.</p><p>I have only a few marginal comments that the author may wish to consider.</p><p>Comment on which cholinergic neurons are responsible for the cold resistance in TIGER knockout mice, peripheral or central?</p></disp-quote><p>Curare only inhibits the acetylcholine receptor present on skeletal muscle although the cholinergic TIGAR knockout will be present in all cholinergic neurons (both peripheral and central). Thus, our data are consistent with a peripheral neuronal effect, but we cannot rule other potential changes in central cholinergic signaling.</p><disp-quote content-type="editor-comment"><p>Central NFkB has an important role in neuronal dendrite growth. Can you rule out NFkB signaling as a contributing factor to enhanced cold tolerance in the TIGER knockout mice?</p></disp-quote><p>Since TIGAR can also regulate NF-κB signaling we also cannot rule out a contributing role from this pathway in altering neuronal growth or action potentials at the present time.</p><disp-quote content-type="editor-comment"><p>There are far too many &quot;data not shown&quot; comments in the paper; please show the data in the supplement (lines 99, 113, 119, 159, 168 and 221).</p></disp-quote><p>As indicated above, we now include the previously data not shown that are pertinent to the conclusions of this study.</p><disp-quote content-type="editor-comment"><p>While acetylcholine production relies heavily on acetyl-CoA availability, another important rate limiting step is the availability of choline controlled by the choline pump on the postsynaptic terminal after acetylcholine is degraded in the junction. This could be the rate limiting step during shivering thermogenesis or exercise. Did you assess expression of this transporter in the mouse models?</p></disp-quote><p>As suggested, we now include immunoblots for the choline transporter (new Figure 4 H) that remains unchanged in these experimental models.</p><disp-quote content-type="editor-comment"><p>TIGER cholinergic neuron specific knockout and whole-body knockout should also have differences in exercise capacity and grip strength. Did the authors assess these physical parameters?</p></disp-quote><p>We have accessed grip strength and exercise capacity, but these parameters were unchanged at room temperature. Since there is no increase in cholinergic signaling at room temperature but only when the mice are subjected to cold stress likely accounts for the absence of any difference at room temperature. In addition, shivering activity and normal muscle contraction in terms of strength and running are markedly different. The former results in symmetric uniformed contractions between fibers whereas shivering results from asymmetric contractions with no net directional force. As far as we are aware, the exact neuronal firing mechanisms responsible for these differences remains unknown.</p><disp-quote content-type="editor-comment"><p>Was there a difference in muscle weights, fiber type or myotube diameter in the TIGER knockout mouse models?</p></disp-quote><p>Muscle mass was unchanged, and we now include H and E staining of the soleus (red) and EDL (white) skeletal muscle that demonstrate no change in muscle fiber size or morphology.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>Was media lactate enrichment examined?</p></disp-quote><p>We have not directly measured media lactate. We did perform Seahorse analyses and although the TKO cells displayed increased oxygen consumption rate (OCR) there was no difference in extracellular acidification rate (ECAR). This could be argued against there being an increase in glycolysis, but lactate formation is a measure of anaerobic glycolysis, necessary for regeneration of NAD<sup>+</sup> for glycolysis maintenance therein, or spillover of pyruvate flux that outweighs PDH activity under normal conditions. In our case, we see increased (mitochondrial) PDH flux, and the increased glucose flux entering the pyruvate pool winds up being metabolized in the TCA cycle rather than converting to lactate. This is particularly true for neurons that uptake lactate and then convert it to pyruvate for energy production in the mitochondria.</p><disp-quote content-type="editor-comment"><p>Provide a more complete description of the H218O study. Was the enrichment data normalized to body water enrichment? If not, please point that out and provide justification (e.g. were the mice body weight and composition matched?). Why was water administered by gavage and IP? The IP water injection is quite a large volume. Was it administered as a saline solution? If not, please justify (i.e. can a pain response be excluded?). How was the timing of the tissue collection chosen? Is this timing indicative steady state ATP turnover, or is it closer to an initial rate?</p></disp-quote><p>A more detailed description of the <sup>18</sup>O water labeling and normalization to body water enrichment is now included in the Method details section.</p><p>Mice body weights and composition were the same as now shown in new Figure 1—figure supplement 1.</p><p>The IP was for a bolus injection to immediately raise the <sup>18</sup>O water enrichment. The gavage was to sustain the enrichment to reach steady state.</p><p>The saline <sup>18</sup>O-water (0.9% NaCl in <sup>18</sup>O water) was used for IP injection. We cannot exclude some discomfort due to the injection. Since the control and TKO mice were treated identically, the differences in labeling are not attributed to a differential pain response.</p><p>The timing was chosen so that labeling reach steady-state that is now provided in the Methods detailed section.</p></body></sub-article></article>